East Tennessee State University

Digital Commons @ East
Tennessee State University
Electronic Theses and Dissertations

Student Works

5-2008

Antigen Trafficking within Chlamydia trachomatisInfected Polarized Human Endometrial Epithelial
Cells.
David Kelley Giles
East Tennessee State University

Follow this and additional works at: https://dc.etsu.edu/etd
Part of the Pathogenic Microbiology Commons
Recommended Citation
Giles, David Kelley, "Antigen Trafficking within Chlamydia trachomatis-Infected Polarized Human Endometrial Epithelial Cells."
(2008). Electronic Theses and Dissertations. Paper 1914. https://dc.etsu.edu/etd/1914

This Dissertation - Open Access is brought to you for free and open access by the Student Works at Digital Commons @ East Tennessee State
University. It has been accepted for inclusion in Electronic Theses and Dissertations by an authorized administrator of Digital Commons @ East
Tennessee State University. For more information, please contact digilib@etsu.edu.

Antigen Trafficking within Chlamydia trachomatis-Infected
Polarized Human Endometrial Epithelial Cells
_________________________________

A dissertation
presented to
the faculty of the Department of Microbiology
East Tennessee State University
In partial fulfillment
of the requirements for the degree
Doctor of Philosophy in Biomedical Sciences
_________________________________
by
David K. Giles
May 2008
_________________________________
Priscilla B. Wyrick, Ph.D., Chair
J. Russell Hayman, Ph.D.
David A. Johnson, Ph.D.
Robert V. Schoborg, Ph.D.
David L. Williams, Ph.D.
Keywords: Chlamydia trachomatis, Inclusion Membrane Proteins (Inc), Azithromycin,
Antigen Trafficking, Antigen Presentation, MOMP, LPS, Endoplasmic Reticulum,
Membrane Vesicles

ABSTRACT
Antigen Trafficking within Chlamydia trachomatis-Infected
Polarized Human Endometrial Epithelial Cells
by
David K. Giles

Chlamydia trachomatis serovars D-K are the leading cause of bacterially-acquired
sexually transmitted infections in the United States. As an obligate intracellular
pathogen, C. trachomatis infects columnar epithelial cells of the genital mucosae and
can cause deleterious sequelae such as pelvic inflammatory disease, infertility, and
ectopic pregnancy. Several chlamydial antigens reach the host cell cytosol prior to the
natural release of chlamydiae at the end of the developmental cycle. While some of
these extra-inclusion antigens traffic to the host cell surface, others remain intracellular
where they are proposed to influence vital host cell functions and antigen trafficking and
presentation. The research herein examines the escape and trafficking of the
immunodominant chlamydial antigens MOMP, LPS, and cHsp60 within C. trachomatis
serovar E-infected polarized human endometrial epithelial cells. Studies using highresolution transmission electron microscopy (TEM) and immuno-TEM report the novel
escape mechanism of chlamydial antigens via vesicles everted/pinched off from the
inclusion membrane, an occurrence observed both in the presence and absence of the
antibiotic azithromycin. These extra-inclusion vesicles were differentiated from Golgi
vesicles and were shown to deliver chlamydial heat shock protein 60 (cHsp60)homologs 2 and 3, but not homolog 1, to the infected cell surface. Examination of the
iron-responsiveness of the three cHsp60 homologs by immuno-TEM revealed a
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significant increase in cHsp60-2 following iron deprivation. Further investigation of the
trafficking of chlamydial MOMP and LPS antigens enveloped within the protective
everted inclusion membrane vesicles within host cells involved density gradient
centrifugation for the separation of epithelial secretory pathway components followed by
SDS-PAGE and Western blot to determine whether the chlamydial antigen-containing
vesicles could fuse with and deliver the antigens to host cell organelles. Coupled with
immuno-TEM, these data confirmed the presence of major chlamydial antigens within
the endoplasmic reticulum of infected host cells. Additionally, chlamydial
lipopolysaccharide (LPS) was co-localized with CD1d, a lipid antigen-presenting
molecule. Collectively, these studies (i) establish a novel escape mechanism for
chlamydial antigens, (ii) identify cHsp60-2 as a marker of iron stress response in C.
trachomatis, and (iii) define for the first time the host cell ER as a destination for
selected chlamydial antigens during infection.
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CHAPTER 1
INTRODUCTION

The family Chlamydiaceae consists of two genera and three species that are
important human pathogens. The genus Chlamydophila comprises C. pneumoniae and
C. psittaci. C. pneumoniae, transmitted human to human, causes respiratory tract
infections and has been linked to atherosclerotic coronary disease. Chlamydophila
psittaci, common in birds and mammals, is responsible for enteric and respiratory
infections. The genus Chlamydia comprises the third major human species C.
trachomatis, of which there are two human biovars—trachoma and lymphogranuloma
venereum (LGV). C. trachomatis is further subdivided into serovars A-K, with serovars
A-C causing the eye disease trachoma and serovars D-K causing sexually transmitted
diseases (STD). The second human biovar, C. trachomatis LGV, instigates an invasive
STD by infecting subepithelial and lymphatic tissues.
C. trachomatis serovars D-K are the most common agents of bacterially-acquired
STD in the United States and worldwide (CDC 2006). The hallmark of genital infections
by serovars D-K is the bacterium’s extended survival and gradual pathogenesis inside
target epithelial cells, resulting in an ability to establish chronic latent or persistent
infections. After causing a typically asymptomatic urethritis or cervicitis, chlamydiae
ascend the genital tract to cause chronic infections involving serious sequelae such as
prostatitis, epididymitis, pelvic inflammatory disease (PID), ectopic pregnancy, and
infertility (Schachter 1999). Furthermore, the Chlamydia-induced cell damage and local

12

immune response may be risk factors for acquiring HIV infection (Ho and others 1995;
Rottingen and others 2001).
C. trachomatis is a Gram-negative obligate intracellular pathogen that infects
columnar epithelial cells of the mucosae. There are two biological and morphological
forms of Chlamydia; the metabolically inactive, environmentally stable elementary body
(EB) and the metabolically active, intracellularly dividing reticulate body (RB). For
growth and propagation, Chlamydia undergoes a unique developmental cycle (Fig. 1.1)
that uses both extracellular (EB) and intracellular (RB) chlamydial forms. First, EB
encounter the epithelial apical surface, where electrostatic interactions occur to bring
EB in close proximity to receptors on the host cell surface (Kuo and others 1972, 1973,
1976). Several chlamydial ligands [heparan sulfate-like glycosaminoclycan (GAG),
major outer membrane protein (MOMP), 60-kDa cysteine rich outer membrane complex
protein OmcB, and heat shock protein 70] and host cell receptors (heparan sulfate
receptor, mannose and mannose-6-phosphate receptors, and the estrogen receptor)
have been implicated in attachment and entry of Chlamydia (Zhang and Stephens 1992;
Chen and Stephens 1994; Su and others 1996; Davis and Wyrick 1997; Rostand and
Esko 1997; Stephens and others 2000; Stephens and others 2001; Davis and others
2002; Kuo and others 2002; Raulston and others 2002; Puolakkainen and others,
2005). Once internalized, the EB-containing endosome bypasses lysosomal fusion,
joins the exocytic pathway and is rapidly redistributed to the perinuclear region. The EB
soon differentiate into RB, which multiply by binary fission within a vacuole termed an
inclusion. The chlamydial inclusion is modified with host cell-acquired lipids (Hackstadt
and others 1996; Wylie and others 1997) and chlamydial proteins to secure an

13

unobtrusive intracellular niche (Hackstadt and others 1997). During chlamydial
development, the introduction of stress, such as antibiotic treatment (Tamura and
Manire 1968; Kramer and Gordon 1971; Tribby and others 1973; Johnson and Hobson
1977; Dreses-Werringloer and others 2000), interferon-γ exposure (Kazar and others
1971; Beatty and others 1993), amino acid deprivation (Allan and others 1985; Coles
and others 1993), and iron restriction (Raulston 1997; Al Younes and others 2001),
causes chlamydiae to enter persistence, defined as the long-term interaction between
chlamydiae and their host cell wherein decreased growth or replication results in a
viable, yet culture-negative, chlamydial form. Chlamydial persistence is becoming
increasingly recognized as a significant phase of development that allows survival under
duress (Beatty and others 1994) and is hypothesized to be the predominant chlamydial
form in infected humans in vivo. Absence or removal of stress allows RB maturation
back into infectious EB to prepare for release by host cell lysis or inclusion extrusion
(Hybiske and Stephens 2007).
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Figure 1.1 The chlamydial developmental cycle, including persistence. (used with
permission from Jane E. Raulston).
Host immune response to C. trachomatis infection begins with the innate defenses
present at the site of infection. In the genital tract, cervical and endometrial epithelial
cells initiate anti-chlamydial immune mechanisms such as cytokine and chemokine
production (Rasmussen and others 1997; Dessus-Babus and others 2000).
Endometrial epithelia also express natural antimicrobials (beta-defensins) and toll-like
receptors and are capable of MHC-I and MHC-II expression and antigen presentation
(Van Eijkeren and others 1991; King and others 2003; Wira and others 2005). The
recognition of chlamydiae elicits activation and recruitment of innate effector cells, such
as polymorphonuclear nuetrophils (PMNs), macrophages, and natural killer (NK) cells
(La Verda and Byrne 1994; Wyrick and others 1999; Hook and others 2004). Therefore,
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to perpetuate infection, chlamydial EB must penetrate epithelial barriers, resist secreted
antibacterial molecules, and avoid phagocytic uptake.
Chlamydial infection induces both an antibody response and a cell-mediated immune
response, although the relative contribution of each of these adaptive immune arms to
the clearance of infection is a matter of debate. Animal models have clearly indicated
that CD4 cells, particularly the Th1 subpopulation, are critical for protective immune
response to genital chlamydial infection (Landers and others 1991; Igietseme and
others 1993). The antibody production from CD4-activated B cells also plays a role in
both the resolution of infection and resistance to reinfection (Ramsey and others 1988;
Igietseme and Rank 1991; Kelly and Rank 1997). However, Morrison and colleagues
(1992) demonstrated that antibodies generated against Chlamydia confer only limited,
serovar specific, protection against reinfection.
Because epithelial cells predominantly present antigens to CD8+ T cells, there has
been an increased focus on the CD8+ T cell response to Chlamydia. CD8+ T cells not
only appear during C. trachomatis infection but also participate in the clearance of the
disease, especially in humans and in other primates (Brunham and others 1985; Beatty
and Stephens 1994; Starnbach and others 1994; Van Voorhis and others 1997; Kim
and others 2000). Such a response implies accessibility of chlamydial proteins to the
cytosol of infected cells, an occurence gaining acceptance due to identification of
chlamydial proteins, including Type III secretion effectors, within the host cell cytosol
(Peters and others 2007). The effort by Chlamydia to evade intracellular immune
detection further substantiates involvement of CD8+ T cells. C. trachomatis can
downregulate MHC-I and MHC-II molecules and produces proteases that may protect
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chlamydial proteins from antigen processing and T cell recognition (Zhong and others
2001; Misaghi and others 2006).
Among the chlamydial antigens that have been shown to play a role in
immunopathogenesis, some of the best studied are the major outer membrane protein
(MOMP), lipopolysaccharide (LPS), chlamydial heat shock protein 60 (cHsp60), and
inclusion membrane protein A (IncA). MOMP, which makes up 60% of total cell
envelope protein, is a protective antigen and a leading vaccine candidate, whereas
LPS, a strong immunogen with unusually long fatty acyl chains, harbors some vaccine
potential despite its low endotoxic activity. Numerous studies have localized chlamydial
LPS exterior to the inclusion yet within the host cell, as well as on the host cell surface
and released extracellularly (Campbell and others 1994; Wyrick and others 1999). As
speculated by Heine and colleagues (2003), such accumulation of LPS in the infected
microenvironment might contribute to the inflammatory response; however, the
demonstrated altered host plasma membrane fluidity, as a result of LPS incorporation,
could also protect the chlamydiae-infected cells from damage by natural killer cell
granzymes and perforin (Wilde and others 1986). Like LPS, cHsp60 can interact with
TLR2, TLR4, and CD14, likely resulting in induction of the inflammatory response
(Ingalls and others 1995; Bulut and others 2002; Darville and others 2003). The
Chlamydia genome contains three cHsp60 homologs, any or all of which may play a
role in establishing chronic chlamydial infection. Recently, IncA, a protein with SNARElike properties and involved in homotypic vesicle fusion (Hackstadt and others 1999;
Delevoye and others 2004), was also identified as an important immunogenic antigen in
human C. trachomatis infection (Tsai and others 2007).
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The recommended treatment for chlamydial infections is the antibiotic azithromycin,
a protein synthesis inhibitor that can access chlamydiae by both spontaneous cellular
uptake and delivery by azithromycin-loaded (in bloodstream) chemotactic PMN
(Raulston 1994; Paul and others 1997). Electron microscopy revealed that the
azithromycin-mediated killing of chlamydiae within infected polarized epithelial cells in
vitro involves an increase in chlamydial outer membrane blebbing (Figure 1.2A,
arrowheads) as well as the appearance of extra-inclusion vesicles (Figure 1.2B,
arrowheads) containing the chlamydial envelope antigens LPS and MOMP (Wyrick and
others 1999). These vesicles, also observed during normal infection, traffic to and
release LPS and MOMP onto the infected cell surface and into the extracellular milieu.
This mid-developmental cycle release of chlamydial antigens, as opposed to natural
release of chlamydiae and antigens at the end of the developmental cycle, may
influence antigen trafficking and presentation by the host cell and contribute to the
prolonged inflammatory response typical of chlamydial infections.

A

B

Figure 1.2 The azithromycin-mediated killing of chlamydiae involves the appearance of
chlamydial outer membrane blebs (A) and vesicles exterior to the inclusion (B).
(adapted from Wyrick and others 1999).
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Specific Aims
The overall goal of this study is to examine the trafficking of chlamydial antigens
within C. trachomatis serovar E-infected polarized human endometrial epithelial cells.
C. trachomatis serovar E is the most common STD isolate in the United States. Initial
experiments focus on elucidating the origin and antigen content of the extra-inclusion
vesicles shown in Figure 1.2B. Of special interest is the destination(s) of these vesicles
and their antigens, particularly whether or not the vesicles intersect host cellular
organelles, such as the endoplasmic reticulum and/or Golgi, leading to the novel
possibility of MHC-I and MHC-II antigen loading and presentation by epithelial cells.
Secondly, specific antisera to the three cHsp60 homolog proteins will be used to probe
C. trachomatis-infected polarized endometrial epithelial cells during normal infection and
iron-deprived infection. The localization and relative expression of the three cHsp60
homologs may provide insight into both their response following stress and participation
in the destructive inflammatory sequelae associated with chlamydial infection.
The Specific Aims of this study are: 1) to determine the origin and antigen content of
the extra-inclusion vesicles observed during chlamydial infection of polarized
endometrial epithelial cells; 2) to explore the destination(s) and immunological
consequences of these extra-inclusion vesicles; and (3) to determine, by
immunoelectron microscopy, the localization and iron-responsiveness of the three
cHsp60 homologs during infection of polarized endometrial epithelial cells.
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CHAPTER 2

ULTRASTRUCTURAL ANALYSIS OF CHLAMYDIAL ANTIGEN-CONTAINING
VESICLES EVERTING FROM THE CHLAMYDIA TRACHOMATIS INCLUSION

David K. Gilesa, Judy D. Whittimorea, Richard W. LaRuea, Jane E. Raulstona,b,
Priscilla B. Wyricka*

Departments of Microbiologya and Pathologyb, James H. Quillen College of
Medicine, East Tennessee State University, Johnson City, TN 37614

*Corresponding author. Mailing address: Department of Microbiology, Box
70579, James H. Quillen College of Medicine, East Tennessee State University,
Johnson City, TN 37614-0579. Phone: (423) 439-8079. Fax: (423) 439-8044.
E-mail: pbwyrick@mail.etsu.edu

Keywords: Chlamydia trachomatis, Inclusion membrane proteins (Inc),
Azithromycin, Antigen escape, vesicle formation
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Abstract
Several chlamydial antigens have been detected in the infected epithelial cell cytosol
and on the host cell surface prior to their presumed natural release at the end of the 7296 h developmental cycle. These extra-inclusion antigens are proposed to influence
vital host cell functions, antigen trafficking and presentation and, ultimately, contribute to
a prolonged inflammatory response. To begin to dissect the mechanisms for escape of
these antigens from the chlamydial inclusion, which are enhanced on exposure to
antibiotics, polarized endometrial epithelial cells (HEC-1B) were infected with Chlamydia
trachomatis serovar E for 36 h or 48 h. Infected cells were then exposed to chemotactic
human polymorphonuclear neutrophils not loaded or pre-loaded in vitro with the
antibiotic azithromycin. Viewed by electron microscopy, the azithromycin-mediated
killing of chlamydiae involved an increase in chlamydial outer membrane blebbing
followed by the appearance of the blebs in larger vesicles (i) everting from but still
associated with the inclusion as well as (ii) external to the inclusion. Evidence that the
vesicles originated from the chlamydial inclusion membrane was shown by immunolocalization of inclusion membrane proteins A, F, and G on the vesicular membranes.
Chlamydial heat shock protein 60 (chsp60) copies 2 and 3, but not copy 1, were
released from RB and incorporated into the everted inclusion membrane vesicles and
delivered to the infected cell surface. These data represent direct evidence for one
mechanism of early antigen delivery, albeit membrane-bound, beyond the confines of
the chlamydial inclusion.
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1. Introduction
The obligate intracellular pathogen Chlamydia trachomatis continues to be the
leading cause of ocular and bacterially-acquired sexually transmitted infections
worldwide. The genital serovariants (serovars D-K) target columnar epithelial cells of
the genital mucosae. Initial chlamydial infection of the lower genital tract typically
induces cervicitis or urethritis that often remain undetected. Without antibacterial
therapy, more serious sequelae can result from ascending infection to the upper genital
tract causing complications such as prostatitis, epididymitis, pelvic inflammatory disease
(PID), ectopic pregnancy, and infertility [1].
The recommended treatment for chlamydial infections is the antibiotic azithromycin
[2], a protein synthesis inhibitor that can access chlamydiae in their intracellular
inclusions by pinocytosis following delivery by azithromycin-loaded polymorphonuclear
neutrophils (PMN) or exogenous addition of the antibiotic to tissue culture medium [3,4].
Although it is not directly cidal to infectious, metabolically-inactive chlamydial
elementary bodies (EB), azithromycin rapidly inhibits chlamydial protein synthesis in
both intracellular reticulate bodies (RB) and purified host-free RB [5]. In vitro
pharmacokinetic analyses revealed both higher cellular uptake and slower release of
azithromycin versus erythromycin especially in polarized versus non-polarized genital
epithelial cells [4,6]. This three-fold uptake of azithromycin in polarized cells is believed
to contribute to the long pharmacological half-life in vivo. Studies with human
phagocytic cells have not only indicated significant accumulation of azithromycin within
monocytes, PMN, and alveolar macrophages, but they have also documented the
transport and delivery of azithromycin by chemotactic PMN to infected cells [3,7]. In
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vitro susceptibility studies have shown the advantages of azithromycin over
erythromycin, doxycycline, and tetracycline [8,9], and clinical studies have reported
single-dose effectiveness and good patient tolerance and compliance [10-12].
Viewed by transmission electron microscopy, the azithromycin-mediated killing of
chlamydiae within infected, polarized human endometrial epithelial cells (HEC-1B)
cultured in vitro reveals a dramatic increase in chlamydial outer membrane blebbing
prior to destruction of metabolically-active RB. In addition, a notable finding is the
appearance during mid-developmental cycle of extra-inclusion vesicles containing
chlamydial envelope antigens [3,13]. These extra-inclusion vesicles can traffic to the
infected cell surface to release chlamydial major outer membrane protein (MOMP) and
lipopolysaccharide (LPS) into the extracellular milieu much prior to release of infectious
progeny, possibly via apoptotic bodies [14], at the end of the developmental cycle.
Furthermore, residual chlamydial envelopes and MOMP and LPS antigens also persist
within inclusions in azithromycin-exposed cells for up to 4 weeks, and PMN chemotaxis
to these antigen-containing epithelial cells can still be triggered in vitro [13]. Such
persistence and slow release of chlamydial antigens, whether antibiotic-induced or not,
may contribute to the hallmark prolonged inflammatory response considered
accountable for the damage and sequelae in chlamydial infections. Importantly, the
premature escape of chlamydial antigens from the membrane-bound inclusion is not
restricted to stressful conditions, induced by antibiotics or immune modulators, but has
been observed to occur during the normal developmental cycle [15-17]. A recent study
by Patton et al. [18] yielded encouraging findings when azithromycin was used as the
treatment in a macaque model of chlamydial pelvic inflammatory disease; azithromycin
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treatment resulted in dramatic reduction of both immunopathologic damage and
inflammatory response as evidenced by the absence of MOMP and chsp60 antigens in
the monkey tissues following hysterectomy.
Native chlamydial MOMP elicits a protective response in chlamydiae-challenged
mice and is a leading vaccine candidate [19,20]. While the unusually long fatty acyl
chains of chlamydial LPS significantly reduce its endotoxic activity, it is speculated that
local accumulation of LPS in the microenvironment of an infected niche may still be
sufficient to promote an inflammatory response [21]. In contrast, several studies have
identified an association between chlamydial heat shock protein 60 (chsp60) and severe
ocular inflammation [22] as well as the deleterious sequelae of genital chlamydial
infection, including tubal infertility, PID, and salpingitis [23-28], although the mechanism
is somewhat controversial [29]. More recently, women with either PID or multiple C.
trachomatis infections were shown to have reduced production of interferon-gamma in
response to chsp60, supporting a role for chsp60 in establishing chronic chlamydial
infections [30]. Whole genome sequencing of C. trachomatis serovar D [31] revealed
two additional hsp60 homolog proteins, chsp60 copies 2 and 3 (chsp60-2 and chsp603) in addition to groEL (chsp60-1). Based on previous data published by the Hudson
laboratory, the expression of these genes is independent of one another and differential
expression has been observed in active versus persistent infection [32].
The purpose of this study was to further investigate the azithromycin-enhanced
extra-inclusion vesicles in chlamydiae-infected cells to determine their origin and to
probe them for the presence of chsp60.
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2. Materials and Methods
2.1. Growth of Chlamydia and eukaryotic host cell
A human urogenital isolate C. trachomatis E/UW-5/CX, originally obtained from S.P.
Wang and C.-C. Kuo (University of Washington, Seattle, WA, USA), has been
maintained in our laboratory for several years. Standardized inocula of C. trachomatis
infectious EB were prepared from McCoy cells grown on Cytodex 3 beads (Sigma) as
described previously [33]. Progeny EB were harvested, titrated for infectivity, and
stored as described previously [34].
The human endometrial epithelial cell line HEC-1B (HTB-113; American Type Culture
Collection, Rockville, Md.), originally derived from a patient with endometrial carcinoma,
was the cell line used in these studies. The HEC-1B cells, grown in a polarized manner
[35] on commercial inserts (BioCoat Matrigel invasive chambers, 0.3 cm2, Becton
Dickinson Labware), were cultivated in Dulbecco’s modified Eagle MEM (Life
Technologies GIBCO-BRL, Grand Island, NY) supplemented with 10% fetal calf serum
(Hyclone, Logan, UT) and 10 mM HEPES, pH 7.3 (DMEM) and maintained at 35°C in
an atmosphere of 5% carbon dioxide and 95% humidified air.

2.2. Azithromycin
The antibiotic azithromycin, obtained from Pfizer Laboratories (Groton, CT, USA),
was first solubilized in ethanol before prepararation of a 1 g/L stock solution in sterile
water. Dilutions were made in DMEM and the antibiotic solutions were stored at 4°C in
the dark.
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2.3. Bacterial infection of cells and exposure to azithromycin
Polarized HEC-1B cells were inoculated with C. trachomatis EB by passive
adsorption with a titre of crude stock diluted to a concentration demonstrated to yield at
least 50% infected cells. In order to simulate the in vivo delivery of azithromycin to
chlamydiae-infected tissues, the antibiotic was delivered to infected cells in vitro by
chemotactic, azithromycin-loaded human polymorphonuclear neutrophils (PMN).
Briefly, Histopaque-purified human peripheral blood PMN, obtained from chlamydiaenegative healthy volunteers via an Institutional Review Board approved protocol, were
either not loaded or pre-loaded with azithromycin (25 mg/L) in vitro. The PMN (106
PMN per 10 µL) were then added to an agarose well underneath the extracellular matrix
(ECM) layer supporting the polarized HEC-1B cells infected for 36 or 48 hours. The
PMN were co-cultured with the chlamydiae-infected cells for 3, 6, or 12 hrs to allow for
PMN activation and basal-to-apical chemotaxis, as detailed before [3,13]. Quantitation
of fluorescence in calcein-AM-loaded PMN revealed 60-120-fold increase in
chemotactic PMNs reaching the ECM layer in 36 h versus 24 h infected monolayers
[36].
Alternatively, azithromycin was delivered exogenously to chlamydiae-infected cells as
a dilution in the growth medium. Azithromycin was added at either 24 or 36 hours postinfection (hpi) and samples were taken every 12 h until the end of the developmental
cycle.
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2.4. Transmission electron microscopy and antibodies
Samples were processed and embedded in Epon-araldite for high contrast or in
Lowicryl (Polysciences, Inc.) for immunoelectron microscopy, as described previously
[15].
The primary antibodies used in this study to detect Golgi markers were (1) goat
polyclonal antibodies directed against AP1G1 (Abcam); (2) monoclonal antibodies
directed against Golgi Complex (Abcam); and (3) rabbit polyclonal antibodies directed
against Giantin (Covance).
The primary antibodies used in this study to detect chlamydial antigens were (1)
monoclonal antibodies directed against inclusion membrane protein A (IncA) generously
donated by Dr. Dan Rockey (Oregon State University, Corvallis, OR); (2) rabbit
polyclonal antibodies directed against IncA (via Dr. Rockey), and IncF and IncG,
generously donated by Dr. Ted Hackstadt (Rocky Mountain Laboratories, Hamilton,
MT); (3) monoclonal antibodies directed against the genus-specific epitope of C.
trachomatis L2 lipopolysaccharide, provided by S. J. Richmond and S. Campbell
(University of Manchester, UK); and (4) monospecific polyclonal antibodies targeted
against three custom-designed 17-21-amino acid peptides in C. trachomatis serovar E
heat shock protein 60kDa (hsp60) homologs, generated commercially in New Zealand
White female rabbits by Sigma-GenoSys. The specific hsp60 peptide domains include
MSRSANEGYDALRDAYT for chsp60-1, IPQEEIGYITSSIRAMTESLR for chsp60-2, and
SQRSGSTLHLVKGIQTQKGY for chsp60-3. Preimmune serum was also provided.
Peptide purity (>95%) was determined by high pressure liquid chromatography (HPLC)
and mass spectral analysis. Enzyme immunoassays to determine the peptide
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reactivities of the preimmune and first bleed antisera were conducted by SigmaGenoSys as part of their quality control. After arrival in our laboratory, the
immunoglobulin G (IgG) fraction of each serum was purified using ImmunoPure Protein
A IgG purification kits (Pierce). Fractions containing 0.5 mg/ml, as assessed using UV
spectrophotometry (280nm), were combined and dialyzed overnight against 10mM
phosphate buffer (pH 7.0, 4°C) prior to storage at -20°C. Aliquots of each serum were
pre-adsorbed against HEC-1B cells and recombinant E. coli LMG194 expressing the
other two chlamydial hsp60 homologs engineered in the arabinose-inducible vector
pBAD(HisA). Western blotting was done to confirm the absence of cross-reactivity to
HEC-1B cell proteins as well as specific reactivity to all chlamydial hsp60 proteins.
Primary antibodies were diluted 1:250 (AP1G1), 1:1 (Golgi Complex), 1:800 (Giantin),
1:30 (IncA polyclonal), 1:10 (IncA monoclonal and IncF polyclonal), 1:50 (chsp60-1),
and 1:20 (chsp60-2) and visualized with a 1:200 dilution of 15-nm gold-conjugated
second-affinity antibodies (Amersham Biosciences).
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3. Results
3.1. Extra-inclusion vesicles in azithromycin-exposed and -unexposed chlamydiaeinfected polarized human endometrial epithelial cells (HEC-1B)
Transmission electron microscopy examination of numerous azithromycin-exposed
chlamydiae-infected HEC-1B samples at 60 hpi confirmed that azithromycin-mediated
killing of chlamydiae involved an increase in chlamydial outer membrane blebbing as
well as the appearance of extra-inclusion vesicles (Fig. 2.1B-E). Similar results were
observed in samples infected for 24 and 36 h followed by 12 h exposure to azithromycin
(data not shown). These vesicles were observed in many forms, ranging from
seemingly empty vesicles of various sizes to vesicles containing membranous blebs
and vesicular material, and they have been located all along the circumference of the
chlamydial inclusion. The extra-inclusion vesicles have also been identified in polarized
infected cells not exposed to azithromycin (Fig. 2.1A), but they are considerably
reduced in number. Further, these extra-inclusion vesicles are not observed in
uninfected cells (data not shown).
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Figure 2.1 Identification by transmission electron microscopy of extra-inclusion vesicles
in C. trachomatis serovar E-infected polarized human endometrial epithelial cells (HEC1B) in the presence or absence of azithromycin. (A) Extra-inclusion vesicles (arrow) are
present but reduced in number in infected cells cultured in the absence of azithromycin.
(B-E) Numerous extra-inclusion vesicles (arrows) are visible in chlamydiae-infected
cells incubated for 48 hrs, followed by exposure for 12 h to chemotactic PMNs preloaded with azithromycin. When the transepithelial PMNs contact infected cells,
degranulation ensues, releasing bioreactive azithromycin which, in turn, is delivered to
the chlamydial inclusion. (B) The initial effect on metabolically-active RB is excessive
outer membrane blebbing (arrowheads) and the subsequent appearance of outer
membrane-derived envelope ghosts (EG) (enlarged in C). (D,E) Eventually, numerous
vesicles exterior to the inclusion appear (arrows), often containing blebs (arrowheads)
and debris. Bars = A,B) 1 µm, C) 500 nm, D,E) 2 µm.
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3.2. Ultrastructural evidence for vesicles originating from the chlamydial inclusion
Extensive high contrast ultrastructural analysis of azithromycin-unexposed (Fig.
2.2A) and azithromycin-exposed (Fig. 2.2B-E) chlamydiae-infected epithelial cells
provided evidence for a direct link between the extra-inclusion vesicles and the
chlamydial inclusion in that vesicles could be visualized actually everting/budding from
the inclusion. A closer examination of the interior of the vesicles revealed the presence
of material that resembled chlamydial remnants from inside the inclusion, i.e. chlamydial
membrane blebs, envelope ghosts, and other debris following azithromycin exposure
(compare Fig. 2.2D, arrowheads and Fig. 2.2E, arrows). Because RB are osmotically
fragile, the environment within the inclusion must be somewhat hypertonic; however, the
turgor pressures involved in vesicle eversion are unclear.
Figures 2.1 and 2.2A-E are representative electron photomicrographs derived from
delivery of azithromycin to the chlamydiae-infected HEC-1B cells via the natural in vivo
mechanism of azithromycin-loaded chemotactic PMNs. Similar morphological results
are obtained when the antibiotic is added exogenously to the tissue culture medium at
24-48 hpi (Fig. 2.2F).
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Figure 2.2 Ultrastructural identification of the formation of vesicles everting from
inclusions of C. trachomatis serovar E-infected epithelial cells in the presence and
absence of azithromycin. (A) A vesicle everting from an inclusion in a HEC-1B cell
infected with C. trachomatis for 60 h in the absence of azithromycin. (B-E) Vesicles
everting from inclusions in epithelial cells infected with C. trachomatis for 48 h and
exposed to chemotactic PMNs pre-loaded with azithromycin for 12 h. Note the vesicle
contents resemble outer membrane blebs like those found inside the inclusion (compare
arrowheads in D and arrows in E). (F) The appearance of vesicles within polarized
HEC-1B cells infected with C. trachomatis serovar E and exposed to azithromycin
added exogenously to the tissue culture medium at 24 hpi and processed for TEM at 48
hpi. Bars = A) 500 nm, B) 2 µm, C-E) 500 nm, F) 4 µm.
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Having identified vesicles in the process of eversion from the inclusion, we sought
confirmation that they were, indeed, chlamydial inclusion membrane in origin.

3.3. Chlamydia-specific inclusion membrane proteins A (IncA) and F (IncF) and G
(IncG) localize to the membrane of extra-inclusion vesicles
In the process of establishing their intracellular niche, chlamydiae produce proteins
that are inserted into and modify the inclusion membrane. These proteins, called
inclusion membrane proteins (Incs), contain a characteristic bi-lobed hydrophobic
domain and have been localized to the inclusion membrane by fluorescence microscopy
[37-41]. Primary polyclonal and monoclonal antibodies generated against IncA and
polyclonal antibodies generated against IncF and IncG were used in the present study
for post-embedding labeling immuno-electron microscopy analysis of the inclusion
everting vesicles; the primary antibodies were detected by colloidal gold-conjugated
second-affinity antibodies.
IncA was located in RB, particularly the outer membrane, as well as on the inclusion
membrane (Fig. 2.3A and B). Both IncA and IncF were observed on areas of the
inclusion membrane appearing to be in the process of everting/budding outward into the
host cell cytosol (Fig. 2.3C, D, and E, circles). Further, IncA was found to be present on
the membranous material within the inclusion membrane vesicles (Fig. 2.3E and F). In
addition to localizing to chlamydial RB and the inclusion membrane, IncA, IncG (data
not shown) and IncF were found on the membranes of vesicles exterior to the inclusion
(Fig. 2.3D, arrows and 2.3E, circle). The immuno-localization of chlamydia-specific
inclusion membrane proteins A, F, and G supports the eversion of these vesicles from
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the inclusion membrane. Controls always included post-exposure of duplicate Lowicryl
sections to (i) gold-conjugated second-affinity antibody alone and (ii) an irrelevant
primary antibody plus gold-conjugated second-affinity antibody (data not shown) to
confirm the specificity of the signal in the test samples.
While Lowicryl is a high contrast resin for immuno-electron microscopy, it is a lower
contrast resin compared with Epon resin; post-fixation staining with osmium tetroxide
and heat curing are omitted to avoid accelerated exothermic reactions that could lead to
antigenic destruction. Therefore, the membranous bleb content of the extra-inclusion
vesicles is not always apparent (compare Figs. 2.3D and 2.5B [Lowicryl] with Figs. 2.2B
and D [Epon]). However, this membranous bleb content has been observed with
definition in Lowicryl (Fig. 2.3F), although to a lesser extent. Because Lowicryl is a low
viscosity, low temperature, photopolymerized resin, all processing was carried out at
4°C and -20°C, reducing the possibility that these everting inclusion membrane vesicles
were artifacts of processing. Finding the same amount and pattern of everting inclusion
membrane vesicles in duplicates of Lowicryl-processed compared with Epon-processed
samples strengthens their existence.
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Figure 2.3 Ultrastructural localization of IncA and IncF. (A) Detection of IncA (polyclonal
antibodies) in RB, associated with the RB outer membrane, and on the inclusion
membrane (circle) at 48 hpi in the absence of azithromycin. (B) Detection of IncA
(polyclonal antibodies) on the inclusion membrane (circles) and associated with RB
outer membranes juxtaposed with the inclusion membrane (squares) during
azithromycin exposure. (C) Detection of IncA (monoclonal antibodies) on an area of the
inclusion membrane appearing to protrude outward into the host cell cytosol (circle) at
48 hpi minus azithromycin. (D) Detection of IncF (polyclonal antibodies) on the surface
of extra-inclusion vesicles (arrows) and on an area of the inclusion membrane
appearing to pinch outward into the host cell cytosol (circle). (E,F) Detection of IncA
(polyclonal antibodies) on membranous material within the inclusion membrane
vesicles. Again, IncA was localized to the inclusion membrane and on the surface of
everting inclusion membrane vesicles (circles). Bars = 500 nm.
3.4. Differentiation between Golgi vesicles and inclusion membrane-derived
vesicles
It has been well-established, via numerous elegant studies from the Hackstadt
laboratory [42,43], that exocytic vesicles from the Golgi are intercepted by and fuse with
the early chlamydial inclusion, resulting in acquisition of spingomyelin and cholesterol
[44] by EB and RB envelopes. Thus, immuno-exposure of Lowicryl thin sections of
azithromycin-exposed, serovar E-infected HEC-1B cells to primary antibodies generated
against the cytoplasmic domain of the membrane-inserted Golgi marker Giantin,
followed by gold-conjugated second-affinity antibodies, did label some chlamydiae and
a few chlamydial envelope blebs within the inclusions and in bleb-containing extrainclusion vesicles. However, the immuno-marker was not detected on the inclusion
membrane nor the membrane of the extra-inclusion vesicles but did label numerous
Golgi vesicles (Fig. 2.4D). Even though C. trachomatis infection distorts the Golgi
complex and Golgi components are difficult to find among the numerous extra-inclusion
vesicles, they could also be detected by additional Golgi markers, including the clathrinassociated adapter protein complex 1 (AP1G1) and the Golgi zone cytoplasmic marker
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(Fig. 2.4A-C). In contrast, these markers were not detected on the inclusion membrane
nor on the extra-inclusion vesicle membranes.

A

C

D

B

Figure 2.4 Ultrastructural localization by post-embedding immuno-electron microscopy
using Golgi markers in chlamydiae-infected epithelial cells exposed to exogenous
azithromycin at 36 hpi for 12 h. (A,B) Detection of the polyclonal Golgi marker AP1G1 in
an area devoid of extra-inclusion vesicles. The low magnification in A illustrates the
abundance of vesicles, while magnification of the box (B) depicts the region labeled by
AP1G1 (circles). (C) Detection of the monoclonal Golgi marker Golgi Complex on
vesicles morphologically distinct from the everting inclusion membrane vesicles. (D)
Detection of the polyclonal Golgi marker Giantin associated with Golgi vesicles (arrows).
Bars = A) 2 µm, B-D) 500 nm.
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From these data, it can be reasoned that (i) azithromycin does not effect Golgi
trafficking but does likely effect chlamydial inclusion membrane composition, (ii) extrainclusion vesicles containing chlamydial outer membrane blebs appear and become
numerous in azithromycin-exposed, C. trachomatis serovar E-infected epithelial cells,
and (iii) the extra-inclusion vesicles routinely and reproducibly label with antibodies to
Inc proteins but rarely with Golgi-specific antibodies whereas Golgi-specific vesicles are
devoid of chlamydial envelope blebs and do not label with antibodies to Inc proteins.
Such findings strongly suggest that the bleb-containing extra-inclusion vesicles are
arising from eversion of the chlamydial inclusion membrane versus representing a Golgi
vesicle “kiss and run” scenario.

3.5. Detection of chlamydial heat shock protein 60 (chsp60) within extra-inclusion
vesicles
Previous studies had demonstrated by immuno-electron microscopy that the outer
membrane blebs in the extra-inclusion vesicles contained the major outer membrane
protein (MOMP) and lipopolysaccharide (LPS) [13] and these findings were confirmed in
the present study (data not shown). Polyclonal monospecific antibodies generated
against specific peptide domains of chsp60-1,2,3 were used for immuno-electron
microscopic analysis to determine if these antigens could also be detected in the
everted inclusion vesicles. Chsp60-1 remained within the chlamydial inclusion confined
to RB (Fig. 2.5A), confirming previous studies [45]. Chsp60-2 was detected in RB,
loose inside the inclusion, within everted inclusion membrane vesicles, on the surface of
host cells, and released extracellularly (Fig. 2.5B). A similar pattern of labeling was
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observed for chsp60-3 (data not shown). The significance of escape from the inclusion
of chsp60-copies 2 and 3 versus copy 1 is unknown at this time. However, the fact that
there is selective escape of chlamydial antigens from the inclusion is supported by the
retention in RB in the inclusion of chlamydial hsp70 and histone protein 1 [45].

B

A

Figure 2.5 Ultrastructural localization by post-embedding immuno-electron microscopy
of chlamydial heat shock protein 60 (chsp60) copies 1 and 2 in chlamydiae-infected
epithelial cells at 48 hpi. (A) Chsp60-1 is confined to RB. (B) Detection of chsp60-2
inside RB, in the chlamydial inclusion, within vesicles everting from the inclusion
(arrows), and on the host cell surface (arrowhead). Bars = 500 nm.
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4. Discussion
Twenty-five years ago, Richmond and Stirling [46] were the first to report the
excretion of C. trachomatis serovar E LPS from the inclusion, concomitant with
RB replication and blebbing; the LPS was subsequently detected on the surfaces
of infected cells and spread to adjacent uninfected cells. These surprising
findings were confirmed in an elegant study by Karimi et al. [47]. C. trachomatis
F- or L2-infected cells were superinfected at 20 hpi with vesicular stomatitis virus;
progeny virus virions budded from the infected cells 8 hr later were enriched with
chlamydial LPS. Wilde and Karimi et al. [48] then employed spin probe electron
spin resonance spectroscopy to show that the fluidity of the LPS-containing
infected cell plasma membrane versus mock-infected plasma membrane was
significantly decreased. The authors speculated that the altered biophysical
properties of the chlamydiae-infected host cell surface could protect the
chlamydiae within from immune-mediated destruction, i.e., cytolysis from a
complement-mediated mechanism or from natural killer or T cells.
That chlamydial LPS-containing outer membrane blebs escaped from the inclusion
mid-developmental cycle was surprising. It was generally assumed chlamydial antigen
escape occurred at the end of the developmental cycle when the inclusion membrane
fused with the infected cell apical plasma membrane to release infectious progeny (Fig.
2.6A). However, additional support also existed in the early transmission electron
microscopic studies of Matsumoto et al. [49].
When these authors added penicillin exogenously to infected cells to induce a
chlamydial persistent state, there was a period of excessive RB outer membrane
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blebbing during the progressive stages of disruption of cell wall biosynthesis. These
blebs, containing LPS and MOMP, appear to “melt” into the inclusion membrane and
emerge on the cytosolic side (Fig. 2.6D and E); perhaps by trafficking on Inc fibers
extending from the inclusion membrane into the cytosol [50]. LPS and MOMP can
subsequently be detected at 48 hpi by immuno-electron microscopy on the surface of
the infected cells and in the extracellular milieu [15]. Proof that Gram-negative bacterial
outer membrane blebbed vesicles can fuse with the plasma membrane of target host
cells, at least from an external direction, as a mechanism to deliver bacterial virulence
factors, DNA, and toxins has been shown in many studies [51-55].
If, however, the prokaryotic protein synthesis-inhibiting antibiotic azithromycin is
exposed to chlamydiae-infected epithelial cells, a different mechanism of chlamydial
outer membrane bleb antigen escape occurs – via vesicles everting from the inclusion
membrane, as revealed in the present study. Because these inclusion membrane
vesicles occur more frequently in the presence of azithromycin, one clever hypothesis
first suggested by Hackstadt was that the inhibition of protein synthesis in metabolicallyactive RB by azithromycin was reducing the production of Inc proteins; thus, reduced
Inc incorporation into the inclusion membrane might result in more fluid inclusion
membrane domains. New studies by the Dautry-Varsat group [56] have provided
additional insight. These investigators have proposed that IncA, previously reported to
be involved in membrane fusion [46,57], can assemble into stable multimeric structures
resembling a SNARE-like membrane fusion complex. Interestingly, heterologous
expression of IncA in HeLa cells resulted in the localization of IncA in the endoplasmic
reticulum (ER). Thus, it is tempting to hypothesize that a potential interaction between
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the small, IncA-positive, everted inclusion membrane vesicles and the ER is possible for
delivery of chlamydial antigens into the lumen of the ER. Further evidence that the
inclusion membrane and, possibly, the membrane of the everted vesicles might
participate in vesicle fusion events with the ER and other host organelles stems from
the extensive studies of Rzomp et al. [58], in which several Rab-GTPases, important
regulators of membrane trafficking, were localized to chlamydial inclusions. Rab1 and
Rab6, which function, respectively, in ER-to-Golgi trafficking and the reverse, were
specifically recruited to C. trachomatis inclusions. The authors also co-localized GFPRab11, involved in receptor recycling to the plasma membrane, with C. trachomatis
IncG; thus, they proposed that interactions between the inclusion membrane and the
host cell may occur via pairings of Inc proteins with Rab-GTPases. Each pairing, either
by direct mediation or following recruitment of effector molecules, is responsible for
fusion and/or motility events with the target membrane. Based on their functions in
eukaryotic cells, Rab-GTPases localized to the chlamydial inclusion could mediate
tethering and fusion with the ER, Golgi and plasma membrane. Taken together, these
studies imply that if the everted membrane vesicles have incorporated the
tethering/fusion machinery, multiple routes of antigen trafficking are likely possible.
It is accepted that CD8+ T cells are primed during chlamydial infection in both mice
and humans [59-61]. To explain how antigens from intracellular pathogens could be
presented to MHC Class I molecules and trigger a CD8+ T cell response, the concept of
cross-presentation has been proposed [62,63]. This model is better suited to
intracellular pathogen antigens, i.e., from Salmonella, Legionella, and Brucella, in
macrophage phagosomes where endoplasmic reticulum organelle dynamic
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convergence occurs [64-66]. Bacterial peptides are proposed to be retro-translocated
to the cytoplasmic side of the phagosome via sec61 for ubiquination and proteosomal
degradation and then translocated back into the phagosome lumen for loading into
MHC Class I molecules. Whether or not the chlamydial inclusion might function
similarly would be considered highly controversial at this time because organelle
dynamic convergence and cross-presentation are not functions of epithelial cells.
However, Wylie et al. [67] have shown that the inclusion membrane acquires some ER
composition. Clearly, the issue of antigen release from the inclusion, and the
implications thereof, for antigen function in the host cell and trafficking are important.
More recently, a chlamydia-specific protein, the Chlamydial Protease-like Activity
Factor (CPAF), has been localized to the cytoplasm of the infected host cells late in
chlamydial infection stages [16,17,68]. This protease degrades both RFX5 and USF-1,
transcription factors essential for expression of MHC Class I and Class II antigens,
respectively. Subsequently, Stenner-Liewen et al. [69] described another late protein
CADD, for Chlamydia protein Associating with Death Domains, found in the host
cytoplasm co-localized with Fas, which may modulate induction of apoptosis until late in
chlamydial development. Finally, Fling and Starnbach and colleagues [60,61]
generated CD8+ T cells cytotoxic for C. trachomatis-infected cells; interestingly, the
antigens used to generate the CD 8+ T cells were an Inc protein and an Inc-associated
protein, Cap1. Thus, chlamydiae are clearly sending signals to the eukaryotic host
cytoplasm, some of which are directed at the immune response. How are those signals
getting from the inclusion?
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It has been postulated that some of these components/antigens may be secreted
into the inclusion membrane and into the infected host cell by the chlamydial type III
secretion system, in this case operating from “inside out” [70]. Support for this idea
comes from the clever strategy of using Yersinia [71-73], Shigella [74], and Salmonella
[75] as heterologous systems for identifying type III secreted effectors, including CopN
and IncC, Tarp, IncA, B, and C from C. pneumoniae, and CopD and Pkn5. The hollow
projections on EB and RB (Fig. 2.6B and C, arrowheads), which originate in the
chlamydial cytoplasm, extend through the envelope, and can pierce the inclusion
membrane [76], were originally proposed by Matsumoto to serve as a conduit for uptake
of nutrients from the host cell cytoplasm for the growing RB. Speculation is popular that
these projection structures are the type III secretion apparatus-equivalent but there is no
information yet on the actual composition of the isolated projections. In any case, these
structures may provide yet another mechanism for communication between this obligate
intracellular vacuolar pathogen and the infected host cytoplasm and for possible
modulation of vital host cell functions. Whether or not this route can be used to deliver
CD8+ T-cell protein antigens to the eukaryotic cytosol for access and classical
presentation to the MHC Class 1 pathway is not known but is being pursued in various
novel approaches.
Finally, the RB outer membrane is associated, at certain times, with the inclusion
membrane (Fig. 2.6C, arrows); this is believed to be a tight association which leaves
chlamydial outer membrane material adhered to/intercalated with the inclusion
membrane after RB dissociation, as evidenced by the retention of darker staining areas
(Fig. 2.6C inset, arrows). Genomic and bioinformatic analyses have suggested that
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some members of the large family of Chlamydia polymorphic outer membrane proteins
(Pmps) are surface exposed, antigenic and phase variable, can form the B-barrel
translocating unit in the outer membrane, and may serve as the type 5 autotransporter
secretion pathway [77-80]. It is unknown if, during RB feeding at the inclusion
membrane, incorporation into the inclusion membrane of bi-directional functioning Pmp
autotransporters might occur for uptake of nutrients as well as secretion of molecules
for modulation of apoptosis and the immune response.
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Figure 2.6 Summary composite illustrating known and suspected methods for escape
of chlamydial antigens from the inclusions in infected human epithelial cells. (A) Apical
release (arrow) of chlamydiae and chlamydial antigens from polarized epithelial cells at
the end of the developmental cycle. (B,C) Intimate association between RB and their
outer membranes and projections and the chlamydial inclusion membrane. Arrows
indicate presence of surface projections extending from the RB outward to the inclusion
membrane. Arrowheads point to the darker staining areas where the RB outer
membrane makes contact with the inclusion membrane. Inset – some darkly-stained
material remains on the inclusion membrane after dissociation of RB (arrowheads).
(D,E) Chlamydial outer membrane blebs, generated in the process of inducing enlarged,
aberrant persistent RB following exposure of infected cells to penicillin G, emerge from
the interior of the inclusion onto the cytosolic side. Bars = A) 10 µm, B) 2 µm, C-E) 500
nm, E,inset) 250 nm.
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In summary, multiple mechanisms apparently exist for escape of chlamydial antigens
from the protected inclusion niche in mucosal epithelial cells, which are beginning to be
re-analyzed in newer contexts. These components likely interact with host cell
components to modulate several vital host functions—probably for the benefit of
chlamydiae. Some antigens, however, may be the initial trigger for an inflammatory
response. That such critical signals originate in non-immune cells prompted Stephens
[35] to propose the “cellular paradigm of chlamydial pathogenesis” wherein the
processes occurring at the infected epithelial cell are necessary and sufficient to
orchestrate the resultant inflammation and fibrosis of disease and chronic sequelae.
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Abstract
Chlamydial heat shock proteins 60kDa (cHsp60s) are known to play a prominent role
in the immunopathogenesis of disease. It is also known that several stress-inducing
growth conditions, such as heat, iron deprivation, or exposure to gamma interferon,
result in the development of persistent chlamydial forms that often exhibit enhanced
expression of cHsp60. We have shown previously that the expression of cHsp60 is
greatly enhanced in Chlamydia trachomatis serovar E propagated in an iron-deficient
medium. The objective of this work was to determine which single cHsp60 or
combination of the three cHsp60 homologs encoded by this organism responds to iron
limitation. Using monospecific polyclonal peptide antisera that recognize only cHsp601, cHsp60-2, or cHsp60-3, we found that expression of cHsp60-2 is responsive to iron
deprivation. Overall, our studies suggest that the expression of cHsp60 homologs
differs among the mechanisms currently known to induce persistence.

Keywords: Chlamydia trachomatis; 60kDa heat shock protein (Hsp60); Iron;
Persistence
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Introduction
Studies have consistently shown that there is a correlation between the production of
chlamydial 60-kDa heat shock protein (cHsp60) antibodies in chlamydiae-infected
patients and adverse disease consequences. These observations appear to be
universal for Chlamydia species and their disease presentations. Early studies of
whether cHsp60 plays a role in immunopathogenesis involved analyses of serum
antibodies from female patients presenting with Chlamydia trachomatis-associated tubal
infertility (7, 52); elevated levels of anti-cHsp60 in the sera of these patients were
significantly associated with disease. A separate group of investigators described the
contribution of cHsp60 in a guinea pig model of trachoma; an intense mononuclear cell
inflammatory response was observed after conjunctival inoculation of cHsp60 following
resolution of a primary ocular infection with Chlamydia psittaci GPIC (37). Patients with
coronary artery disease often have serological evidence of previous infection by
Chlamydia pneumoniae (45), and cHsp60 has been directly identified in human
atheromatous tissue (31). Most recently, C. pneumoniae and Chlamydia pecorum
cHsp60s have been implicated in urogenital tract disease in koalas (Phascolarctos
cinereus), leading to infertility and death; chlamydiae are the most commonly
recognized disease agents in the threatened koala population (23, 24).
Studies to determine the role of cHsp60 and immunopathogenesis are still being
performed. Recently, workers have examined the initial interactions of cHsp60 with
host cells that induce an inflammatory response. For example, cHsp60 interacts with
Toll-like receptor 4, which stimulates the proliferation of human vascular smooth muscle
cells (47), activates macrophages, and activates endothelial cells (8). The interaction
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between cHsp60 and Toll-like receptor 4 also leads to apoptosis in primary human
trophoblasts, placental fibroblasts, and a trophoblast cell line by both caspasedependent and -independent pathways (18). cHsp60 and other microbial ligands can
also activate mononuclear cells by binding to CD14, the monocyte receptor for
lipopolysacharide (32). Although cHsp60 clearly plays a prominent role in chlamydial
pathogenesis, it is not the only molecule involved. The genetically linked cHsp10,
encoded by the groES gene upstream of groEL-1, is also associated with disease
complications (6, 23, 27, 33). Moreover, several studies have demonstrated that
genetic predisposition plays a significant role in chronic chlamydial disease (10, 12, 38).
Perhaps most interesting is the fact that cHsp60 has been used in a human trial
involving women at high risk for C. trachomatis infection; cHsp60 was used to stimulate
the patients’ peripheral blood mononuclear cells to produce gamma interferon (IFN-γ),
and the results indicated that a protective response against incidental infection
developed (11).
Our laboratory is involved in identifying and analyzing C. trachomatis proteins that
respond to iron restriction, as well as the mechanisms involved (42, 43, 55); cHsp60 is
one of several proteins whose expression increases significantly during iron limitation in
vitro (43). It is known that iron sources and the availability of iron fluctuate in
menstruating women due to the cyclic pressures of estrogen and progesterone (1, 29);
active or persistent C. trachomatis organisms in the reproductive tract are therefore
likely to respond to this dynamic environment using transcriptional, translational, or
posttranslational mechanisms to alter the production of specific chlamydial proteins.
While we are not involved in direct studies of persistent chlamydiae, which have been
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defined as viable but non-culturable organisms (3), iron deprivation is one of several
modes for induction of persistent chlamydiae (22, 39, 43). In women with tubal factor
subfertility, cHsp60 is a serological marker for persistence (15) along with chlamydial
proteasome/protease-like activity factor (48). However, the result of recent studies with
C. psittaci (22) and C. pneumoniae (39) indicate that cHsp60 is not a general marker for
persistence.
When the complete sequence of the C. trachomatis serovar D chromosome became
available, one of many surprises was that there are three open reading frames (ORF)
that code for groEL-related proteins (49). These ORF are positioned in separate
regions of the chromosome and designated as follows: CT110 or groEL-1, encoding
cHsp60-1; CT604 or groEL-2, encoding cHsp60-2; and CT755 or groEL-3, encoding
cHsp60-3. Only groEL-1 is preceded by groES. Matching cHsp60s in different
Chlamydia species appears to be conserved in the sequences that are currently
available. For example, the predicted level of amino acid sequence identity between
cHsp60-1 in C. trachomatis serovar D and cHsp60-1 in C. pneumoniae AR39 is 91%.
However, there are considerable differences between cHsp60-1, cHsp60-2, and
cHsp60-3 in a given species or serovariant. In C. trachomatis serovar D, the levels of
amino acid identity and similarity between cHsp60-1 and cHsp60-2 are 23% and 19%,
respectively; the levels of amino acid identity and similarity between cHsp60-1 and
cHsp60-3 are 18% and 20%, respectively; and the levels of amino acid identity and
similarity between cHsp60-2 and cHsp60-3 are 17% and 15%, respectively (28, 35, 49).
Although the majority of previous studies clearly involved cHsp60-1, as confirmed by
sequence analysis, certain studies, including our study (43), generated new questions
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concerning the extent to which each cHsp60 responds to a given microenvironment,
especially a microenvironment leading to chlamydial persistence. Thus, the purpose of
this study was to determine which cHsp60 is iron responsive in C. trachomatis serovar
E.

Materials and methods
Bacterial strains, eukaryotic host cells, and growth
Stock inocula of C. trachomatis serovar E/UW-5CX EB were generated in McCoy
cell fibroblasts and titrated to determine their infectivity. Polarized human endometrial
epithelial cells (HEC-1B) were used as host cells in iron deprivation experiments and
were maintained in Eagle’s minimal essential medium containing 2 mM glutamine and
5% (vol/vol) heat-inactivated fetal bovine serum at 37°C. For induction of iron
deprivation, chlamydiae-infected cultures were allowed to grow to 36 hrs postinoculation (hpi) and one-half of the samples were exposed to 500 µM Desferal for 30
min and 1 hr and 2 hrs.
Escherichia coli LMG194 (pBAD/HisA) was used to engineer and overexpress each
cHsp60. The recombinants expressing cHsp60-1, cHsp60-2, and cHsp60-3 were
designated as E. coli LMG194 (pJER516), E. coli LMG194 (pJER517), and E. coli
LMG194 (pJER518), respectively. Each recombinant E. coli was grown in reduced
medium (Invitrogen, Carlsbad, CA) containing 0.2% (wt/vol) glucose and 100 µg/ml
ampicillin (Sigma Genosys, The Woodlands, TX) to the mid-log phase (A600, 0.4 to 0.6)
at 37°C. Cultures were subsequently centrifuged, washed, and resuspended in
prewarmed glucose-free medium. Arabinose was then added to each culture for 4 h of
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induction. Maximum expression of cHsp60-1and cHsp60-2 in E. coli LMG194
(pJER516) and E. coli LMG194 (pJER517) required 0.002% (wt/vol) arabinose,
whereas maximum expression of cHsp60-3 in E. coli LMG194 (pJER518) required 20%
(wt/vol) arabinose.

DNA amplification, cloning, and sequence analysis
The primers used for the PCR amplification of the chlamydial groEL genes were
designed using the genome sequence of C. trachomatis serovar D (49). The reactions
were carried out with an Expand High Fidelity PCR system kit (Roche, Nutley, NJ) in the
presence of 0.5 pmol of forward, 0.5 pmol of reverse primer, and 10-fold (1:10-1:1,000)
dilutions of C. trachomatis serovar E DNA template. After 35 cycles of amplification, the
PCR products were cleaned-up using a QIAquick PCR purification kit (Qiagen,
Germantown, MD); the sizes and concentrations of the purified products were
monitored by agarose gel electrophoresis in the presence of ethidium bromide and by
determining the optical density, respectively. All PCRs were done in duplicate to reduce
introduction of errant nucleotides. The PCR products were then directionally cloned into
the pBAD/HisA vector (Invitrogen, Carlsbad, CA), under the control of the araC
promoter with a N-terminal six-histidine tag for recombinant protein detection and used
to transform E. coli LMG194 by the traditional CaCl2 method (46). For each groEL gene,
the recombinant plasmids from three clones were purified using the Concert nucleic
acid purification kit (Invitrogen) and then sequenced to verify in-frame cloning and to
determine the complete nucleic acid sequences.
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Peptide antibodies
The predictive amino acid sequences of C. trachomatis serovar E Hsp60-1,
Hsp60-2, and Hsp60-3 were aligned using the EditSeq and MegAlign software from
DNAStar, Inc. (Madison, WI). Peptides that were 17 to 21 residues long, detailed by
Giles et al. (21), were commercially synthesized, the purity was assessed by analytical
high-pressure liquid chromatography and mass spectroscopy, and each peptide was
subsequently used to immunize two female New Zealand White rabbits (SigmaGenosys, The Woodlands, TX). The results of enzyme-linked immunosorbent assays
were provided by the manufacturer to ensure reactivity.
The majority of antiserum from each bleed was immediately stored at -20°C upon
receipt. One milliliter of antiserum from each bleed was kept at 4°C to determine to
determine the Western blot reactivities of the crude preimmune and immune sera
against total protein from HEC-1B cells and E. coli LMG194 as controls and arabinoseinduced recombinant E. coli LMG194 (pJER516), E. coli LMG194 (pJER517), and E.
coli LMG194 (pJER518). Immune sera exhibiting the most selective reactivity with the
intended Hsp60 homolog were then placed on protein A columns (ImmunoPure
immobilized protein A, Pierce, Rockford, IL) to purify immunoglobulin G, and Western
blotting was performed to determine the degree of monospecificity and the reduction in
the cross-reactivity with other E. coli proteins. Antiserum against the peptide from
cHsp60-3 required a further step of adsorption against whole cells of arabinose-induced
E. coli LMG194 (pJER516) expressing cHsp60-1. A monoclonal antibody reagent
(Sigma-Genosys, The Woodlands, TX) against the polyhistidine tag was also used in
this study.
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Protein quantitation, sodium dodecyl sulfate-polyacrilamide gel electrophoresis,
Western blotting, and chemiluminescence
The total protein concentrations of samples were determined using the Micro
BCA Assay (Pierce, Rockford, IL). Cell pellets were resuspended in lysis buffer (10 mM
Tris-HCl, 1 mM EDTA, 0.5 mg/ml lysozyme, 0.1 mg/ml DNase I, and 10 mM CaCl2) and
subjected to three freeze-thaw cycles. After the final thaw, samples were centrifuged at
8,000 X g for 10 min, and each supernatant was combined with denaturing sample
buffer and heated at 100°C for 5 min. The proteins were resolved in small-format 412% Bis-Tris NuPAGE gels (Invitrogen, Carlsbad, CA) and transferred to nitrocellulose
membranes for Western blotting. Preliminary separations were conducted in largeformat 12.5% polyacrylamide gels loaded with 1 mg of protein to accommodate multiple
blots for screening and titrating antisera.
For Western blotting, membranes were blocked with Blotto-plus (5% [wt/vol] dry nonfat milk in phosphate-buffered saline, 0.1% [vol/vol] Tween 20, and 10% [vol/vol] heatinactivated fetal bovine serum), and washing was performed with phosphate-buffered
saline containing 0.1% (vol/vol) Tween 20. Various dilutions were examined for the
polyclonal peptide antisera generated against each of the cHsp60s, and a monoclonal
antibody against the poly-His tag (Sigma-Genosys, The Woodlands, TX) was also used
as a control. Specific signals were then detected either (i) by a colorimetric assay with
an anti-rabbit alkaline phosphatase-conjugated secondary antibody and Western Blue
substrate (Promega, Madison, WI), or (ii) by chemiluminescence using an anti-rabbit
horseradish peroxidase conjugate, the SuperSignal West (Pierce) solution, and Kodak
X-OMAT AR film.
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Electron microscopy
Samples of C. trachomatis-infected polarized HEC-1B cells at 36 hpi were
exposed to 500µM Desferal for 30 min and 1 h and 2 h; mock-exposed samples were
used as controls. Each sample was immediately washed, fixed, processed, and
embedded in Epon-araldite and Lowicryl (Polysciences, Inc.) for high-contrast electron
microscopy and immunoelectron microscopy, respectively, as described by Giles et al.
(21).
Visualization and image capture were done using a Philips Tecnai 10
transmission electron microscope (FEI Company, Hillsboro, Oregon) operating at 80 kV.

Nucleotide sequence accession numbers
The sequences determined in this study have been deposited in the GenBank
database under the following accession numbers: AY447001 for C. trachomatis serovar
E groEL-1, AY447002 for C. trachomatis serovar E groEL-2, and AY447003 for C.
trachomatis serovar E groEL-3.
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Results
Amplification and nucleotide sequence analysis of C. trachomatis serovar E groEL ORF
DNA that was the expected size was amplified with all dilutions of the C.
trachomatis serovar E groEL DNA templates except the groEL-3/CT755 template (Fig.
3.1A, lanes 3). Figures 3.1B and 3.1C show the results of a change in primer strategy,
and the data revealed that CT755 was present along with the flanking sequences.
Further analysis showed that a missing cytosine residue in the initial sequence of the
CT755 in serovar E at position 25 was responsible for the lack of primer hybridization
and amplification (Fig. 3.1D). As determined by comparison with the published
sequence of CT755 in serovar D, a frameshift placed the ORF back into frame by
insertion of a cytosine residue at position 30 in serovar E. The final results were
confirmed using a new set of primers (Figure 3.1E). The nucleotide sequences of C.
trachomatis serovar E groEL-1, groEL-2, and groEL-3 are 99.7%, 98.5%, and 99.2%
identical to their counterparts in C. trachomatis serovar D, with only 6-, 25-, and 8-bp
differences, respectively.
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Figure 3.1 PCR amplification of C. trachomatis serovar E groEL. (A) Initial attempt to
amplify groEL-1, groEL-2, and groEL-3 (lanes 1, lanes 2, and lanes 3, respectively) from
C. trachomatis serovar E DNA template and primers based on the sequence of C.
trachomatis serovar D. (B) Strategy used to amplify groEL-3 and flanking sequences.
(C) Result of amplification of groEL-3 and flanking sequences. Lanes 1 through 5
contained areas indicated in panel B, and amplification of groEL-1 was used as a
control. (D) Difference in the starting sequences of C. trachomatis serovars D and E.
(E) Amplification of C. trachomatis serovar E groEL-1, groEL-2, and groEL-3 with
redesigned primers for groEL-3.
Specificity of the peptide antisera
Monospecificity was achieved for anti-cHsp60-1 and anti-cHsp60-2 with
purification of immunoglobulin G alone (Fig. 3.2A). Antiserum against cHsp60-3 initially
exhibited faint cross-reactivity with Hsp60-1 that was removed by cross-adsorption
against whole cells of arabinose-induced E. coli LMG194 (pJER516) expressing
cHsp60-1. A control using an anti-histidine monoclonal antibody (Sigma-Genosys, The
Woodlands, TX) was included.
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Iron-responsiveness of cHsp60s
Next, the peptide antibodies were used to examine C. trachomatis-infected cells
with or without 500 µM Desferal, which were exposed for 30 min and 1 h and 2 h,
beginning at 36 hpi (Fig. 3.2B). Preliminary experiments using the standard 50 µM
Desferal for 96 h resulted in induction of a persistence-like state (43); these initial
experiments indicated that only cHsp60-2 responds to iron deprivation beginning at 36
hpi (data not shown). Therefore, we changed the strategy in a manner analogous to
application of heat, cold, or acid shock in other bacteria. Figure 3.2B confirms that
cHsp60-2 is the primary cHsp60 that responds to iron limitation. Notably, cHsp60-2 is a
target of proteolysis during cell lysis even in the presence of protease inhibitors (several
combinations of inhibitors were tested). The data also showed that cHsp-1 is strongly
expressed, but there was little or no difference between the expression in the absence
of Desferal and the expression in the presence of Desferal; cHsp60-3 expression was
delayed, but again, there was little difference between expression in the absence of
Desferal and the expression in the presence of Desferal.
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Figure 3.2 Specificity of peptide antisera and response of cHsp60-2 to iron deprivation.
(A) Samples used for Western blotting included uninfected HEC-1B cells, E. coli
LMG194 alone, and arabinose-induced recombinants E. coli LMG194 (pJER516), E.
coli LMG194 (pJER517), and E. coli LMG194, representing cHsp60-1, cHsp60-2, and
cHsp60-3, respectively. An anti-His tag monoclonal was used as a control (upper left
panel). (B) Samples included uninfected HEC-1B cells (control) (lanes C), cells mock
exposed for 30 min and 1 h and 2 h, and cells exposed to Desferal for 30 min and 1 h
and 2h. One milligram of protein was loaded onto preparative gels (A), whereas 15 µg
was loaded into each lane in panel B. Arrowheads indicate the position of cHsp60. The
asterisk indicates the position of a major proteolytic product of cHsp60-2, and the circle
indicates the position of a cross-reactive protein in HEC-1B cells.
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Immunoelectron microscopy
To confirm that C. trachomatis cHsp60-2 is iron responsive, the final experiment
involved examination of thin sections by immunoelectron microscopy. Multiple images
were captured, saved as TIFF files, and printed; 2 µm square grids were used to
enclose 10 to 15 randomly selected squares containing chlamydial reticulate bodies
(RB) on prints of each sample, and the gold particles in each box were counted (Fig.
3.3).
Figure 3.3A, C, and E represent chlamydial RB in HEC-1B cells at 36 hpi (mock
exposure); Figure 3.3B, D, and F illustrate RB at 36 hpi in cells that were exposed to
500µM Desferal for 1 h. Consistent with the results of the Western blot analyses,
cHsp60-1 was strongly expressed, but there was not a significant difference between
mock-exposed chlamydiae and chlamydiae exposed to Desferal (Fig. 3.3A and B); the
number of particles in Figure 3.3A and B for cHsp60-1 were 19 (+/- 8) and 18(+/- 6),
respectively. Likewise, for weakly expressed cHsp60-3 there was no difference
between mock exposure and exposure to Desferal; the numbers of gold particles in both
Fig. 3.3E and F were 5 (+/- 2). However, there was a significant difference (P < 0.001)
between expression of cHsp60-2 between mock exposure and exposure to Desferal
(Fig. 3.3C and D), as determined by Student’s two-tailed t test; the numbers of gold
particles in Fig. 3.3C and D were 4 (+/- 2) and 10 (+/- 3), respectively.
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Figure 3.3 Immunolabeling transmission electron microscopy showing the response of
cHsp60-2 to iron limitation. Chlamydia-infected HEC-1B cells at 36 hpi were either not
exposed to Desferal (A, C, and E) or exposed to 500µM Desferal (B, D, and F) for 1 h
and labeled using a 1:100 (vol/vol) dilution of anti-cHsp60-1 (A and B), a 1:20 (vol/vol)
dilution of anti-cHsp60-2 (C and D), or a 1:40 (vol/vol) dilution of anti-cHsp60-3 (E and
F). A 15nm gold-conjugated anti-rabbit serum (Amersham Biosciences) was used at a
1:200 (vol/vol) dilution for visualization. Bars = 0.5 µm. The arrowheads indicate gold
particles.
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Discussion
In this report we show conclusively that C. trachomatis serovar E Hsp60-2 is the
primary cHsp60 that exhibits enhanced expression in response to iron restriction. In a
larger context, the specificity of cHsp60-2 expression as a result of iron limitation
indicates that the mechanisms for development of chlamydial persistence have unique
signatures. This is an emerging concept in the study of chlamydial pathogenesis. The
expression of cHsp60s, as determined by either protein expression or transcript
analysis, has been examined in several models of persistence (2, 4, 17, 19, 22, 39).
Belland et al. (4) conducted a comprehensive microarray study of C. trachomatis
serovar D transcription and compared standard growth and growth of IFN-γ-mediated
persistent chlamydiae in HeLa 229 cells. None of the groEL transcripts varied
significantly for the first 24 h; however, by 48 hpi, transcription of groEL-1 increased 2.8fold due to tryptophan depletion by IFN-γ. Tryptophan is an essential amino acid for C.
trachomatis. A separate group of investigators examined transcription using
quantitative real-time PCR for three distinct modes of persistence, exposure to IFN-γ,
penicillin G, and iron depletion, in C. psittaci growing in HEp-2 cells (22). At 24 hpi,
groEL-1 was upregulated only in the penicillin G model of persistence; IFN-γ persistence
actually showed a significant downregulation of groEL-1. Downregulation of groEL-1
was also observed for 48 hpi for C. psittaci persistence induced by iron deprivation;
groEL-2 was not examined in this study. Using a different stress environment,
Karunakaran and colleagues (28) examined transcription using a heat shock model.
HeLa 229 cells were infected with C. trachomatis serovar D for 18 h and subsequently
subjected to a 10-min heat pulse at 45°C. mRNA was quantified using a microarray
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procedure, and the results showed that there was a >5-fold increase in groEL-1
transcripts; the quantities of the groEL-2 and groEL-3 transcripts did not change. In
studies of protein expression, expression of C. trachomatis serovar A cHsp60-1, as
determined using Western blotting and an anti-cHsp60-1 monoclonal antibody, was
enhanced in an in vitro model of IFN-γ-mediated persistence (2). For C. pneumoniae
cHsp60-1, there was a twofold increase in expression at 48 hpi with the following three
different models of persistence and/or stress: (i) IFN-γ exposure, (ii) iron deprivation,
and (iii) heat shock (39).
Our findings are more consistent with results reported by Gerard and colleagues
(20). These investigators quantified mRNA for each groEL homolog in C. trachomatis
serovar K using real-time reverse transcription-PCR with the following systems: (i)
active infection in HEp-2 cells, (ii) persistent infection in human monocytes, and (iii)
synovial tissue from patients with Chlamydia-associated arthritis. In active HEp-2 cell
infection, all groEL transcripts were present beginning at 8 hpi, and the levels increased
throughout chlamydial development; groEL-3 was transcribed at the highest levels. In
the monocyte persistence model, the levels of groEL-1 and groEL-3 transcripts were
low, whereas the level of the groEL-2 transcripts increased threefold over 3 days as the
organisms entered the persistent state. Findings for the synovial tissues also showed
that the levels of groEL-2 transcripts were high. Comparisons with this model of C.
trachomatis serovar K persistence in monocytes may not be entirely legitimate because
our model involves C. trachomatis serovar E, a less invasive organism, in epithelial
cells, but the observations are intriguing nonetheless.
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From the standpoint of immunopathogenesis, the importance of cHsp60s in disease
has been the subject of several excellent reviews (9, 13, 14, 16, 26, 30, 34, 40). Our
previous work, performed with the antisera generated in this study, showed that
cHsp60-2 and cHsp60-3, but not cHsp60-1, escape from chlamydial inclusions via
vesicle eversion, a process that is exacerbated by exposure to azithromycin (21, 44).
The vesicles are thought to interact with host cell antigen presentation and to contribute
to the inflammatory response. Studies of heat shock proteins, in general, are being
performed because heat shock proteins carry antigens and deliver peptides to the major
histocompatibility complex, thus priming the adaptive immune response by inducing
specific B and T cells in the absence of adjuvants (41). Heat shock proteins also
participate in the innate immune response by stimulating the production of chemokines
(41). In one study, cHsp60 serum antibodies were shown to serve to be the best
predicting factor for tubal factor infertility (51). Mapping of cHsp60-1 peptide epitopes in
human sera has been done (50, 54); it may be worthwhile to investigate whether
peptides of cHsp60-2 and/or cHsp-3 contribute to the generation of specific
immunoglobulins.
GroEL proteins are essential for bacterial growth and ensure that newly synthesized
proteins are functional; expression of GroEL proteins increase in response to a variety
of stresses, including heat shock and nutrient deprivation (56). Structural studies of
cHsp60s have shown that although the primary amino acid sequences of cHsp60s differ
from the primary amino acid sequences of other organisms, amino acid residues
involved in binding polypeptides are conserved (28). It is also clear that cHsp60-1 is
negatively regulated by the interaction of a negative regulator, HcrA, with a CIRCE
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element in the operator regions of the groES-groEL-1 and dnaK operons; HrcA does
not appear to regulate groEL-2 or groEL-3 (53). Although the results of studies of C.
trachomatis serovar K persistence and synovial fluid support the hypothesis that there is
regulation of chlamydial groEL-2 at the level of transcription, there appears to be no
Fur/DcrA binding site in upstream sequences. There is only a partial Fur box
approximately 300 bp downstream in C. trachomatis serovar E groEL-2; determining
whether DcrA binds to groEL-2 sequences is part of a separate project in our laboratory.
A likely alternative mechanism for enhanced expression of cHsp60-2 may involve small
RNAs that regulate genes posttranscriptionally or by stabilization of mRNA; numerous
iron-responsive proteins in other bacteria are known to be regulated in this fashion (25).
Chlamydiae code for several small RNAs (5). Finally, the increased level of cHsp60-2
might also involve protein stability. For example, when E. coli GroEL is bound to an
unfolded substrate in vitro, the complex remains stable at 25°C for more than 2 weeks;
at 43°C, the half-life is 1.5 h (36).
Overall, the results of this study and our previous work (21, 43) strongly indicate that
cHsp60-2 should be considered a potential mediator of immune-mediated damage, and
they mechanistically indicate that not all modes of chlamydial persistence are identical.
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Abstract
Confinement of the obligate intracellular bacterium Chlamydia trachomatis to a
membrane-bound vacuole, termed an inclusion, within infected epithelial cells neither
prevents secretion of chlamydial antigens into the host cytosol nor protects chlamydiae
from innate immune detection. However, the details leading to chlamydial antigen
presentation are not clear. By immunoelectron microscopy of infected endometrial
epithelial cells, chlamydial MOMP, LPS, and the inclusion membrane protein A (IncA)
were localized to the endoplasmic reticulum (ER) and co-localized with multiple ER
markers, but not with markers of the endosomes, lysosomes, cis-Golgi, nor
mitochondria, in isolated cell secretory compartments. Chlamydial LPS was also colocalized with CD1d in the ER. Because the chlamydial antigens, contained in everted
inclusion membrane vesicles, were likely delivered to the ER by a novel fusion process,
these data raise additional implications for antigen processing by infected uterine
epithelial cells for classical and non-classical T cell antigen presentation.

Keywords: Chlamydia trachomatis; Inclusion membrane protein (Inc); LPS; endoplasmic
reticulum; antigen trafficking; antigen presentation
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Introduction
Chlamydia trachomatis serovars D-K, obligate intracellular bacteria that primarily infect
genital mucosal epithelial cells, are the leading cause of bacterial sexually transmitted
disease (STD) in the USA and worldwide (Schachter, 1999). Chlamydial infection and
propagation rely upon a developmental cycle during which an extracellular, infectious
form termed the elementary body (EB) gains entry into the host cell before
differentiating into an intracellular, metabolically-active reticulate body (RB). Inside the
host cell, RB replicate by binary fission within a membrane-bound vacuole termed an
inclusion. Redifferentiation of RB back into EB prepares the infectious progeny for
release, through a mechanism recently shown to involve two pathways: host cell lysis
and inclusion extrusion (Hybiske and Stephens, 2007). Incomplete chlamydial egress
can result in retention of bacteria within the surviving host cell, creating a unique
condition for persistence of C. trachomatis (Beatty, 2007).
Vital to chlamydial pathogenesis is the establishment of an unobtrusive intracellular
niche that avoids immune detection for the duration of host cell occupancy. To achieve
this residency, the chlamydial EB-containing endosome quickly dissociates from the
endocytic-lysosomal pathway and intersects the exocytic pathway, during which
Chlamydia acquires amino acids, nucleotides, and lipids from the host cell (McClarty,
1994). Additionally, host cell sphingomyelin and cholesterol are obtained by chlamydiae
following interception of trans-Golgi-derived vesicles intended for transport to the
plasma membrane (Carabeo et al., 2003; Hackstadt et al., 1996). More recently, the
late endocytic pathway has been implicated in the delivery of biosynthetic precursors to
the chlamydial inclusion via multivesicular bodies (Beatty, 2006) and Al Younes et al.
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(2004) have proposed an association between Chlamydia and the autophagic pathway.
The ever-growing interactions between Chlamydia and host cell organelles/vesicles are
clues for solving the biology by which this intracellular pathogen succeeds in masking
itself, perhaps temporarily, within the host cell.
Epithelial cells in the genital tract are also gaining recognition for their innate immune
capabilities (Wira et al., 2005). Human endometrial cells exhibit both MHC Class I
(MHC-I) and Class II (MHC-II) expression and antigen presentation (Van Eijkeren et al.,
1991), secrete and respond to cytokines, and express Toll-like receptors. While
chlamydial infection induces adaptive immune protection that involves both humoral and
cellular responses (Roan and Starnbach, 2008), C. trachomatis also employs several
strategies to evade the immune system, including the downregulation of MHC-I and
MHC-II molecules, production of deubiquitin- and deneddylate-specific proteases for
possible protection of secreted proteins from antigen degradation/T cell recognition,
inhibition of host cell apoptosis and entering a persistent state (Fan et al., 1998; Misaghi
et al., 2006; Zhong et al., 2001). Despite residence of the organisms in an intracellular
inclusion niche during infection, several chlamydial proteins, including Type III secretion
(T3S) effectors, have been identified within the host cell cytosol (Peters et al., 2007).
Our laboratory previously reported the formation of chlamydial antigen-containing
vesicles everting from the inclusion (Giles et al., 2006). These everted vesicles were
identified as arising from the inclusion membrane by the presence of the Chlamydiaspecific incorporated inclusion membrane protein A (IncA) and they contained several
immunodominant chlamydial antigens, including the major outer membrane protein
(MOMP) and lipopolysaccharide (LPS). While some of these extra-inclusion antigen
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vesicles traffic to the host cell surface, others remain intracellular where they are
conjectured to influence vital host functions and antigen trafficking and presentation.
Interestingly, elegant studies in the Subtil laboratory have unlocked the possibility of
fusion events between the endoplasmic reticulum (ER) and the inclusion membrane via
the SNARE-like properties of IncA (Delevoye et al., 2004). Because the ER is central to
antigen processing and presentation and has been linked experimentally to chlamydial
IncA, this organelle is an intriguing destination for chlamydial antigens.
The present study examines the host cellular localization of chlamydial antigens,
particularly MOMP, LPS, and IncA within C. trachomatis-infected human endometrial
epithelial cells. Using density gradient centrifugation for isolation of epithelial secretory
pathway compartments and high resolution immunoelectron microscopy, the study
associates these chlamydial antigens with the ER of infected endometrial epithelial
cells, a finding that has implications for host cell antigen processing and presentation.
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Results
Ultrastructural Localization of Chlamydial Antigens within Tracts of Endoplasmic
Reticulum (ER)
Despite the lack of definitive evidence for contact between the chlamydial inclusion
membrane and host cell membranes, numerous studies using electron and confocal
microscopy have observed a close association between the inclusion and various host
cell organelles (ER, Golgi, mitochondria; Hackstadt et al., 1996; Matsumoto, 1981;
Wylie et al., 1997). In our laboratory, the intimate association between the ER and the
chlamydial inclusion membrane has been noted, at least ultrastructurally, across a
breadth of research projects. Until the present study, this recurring phenomenon had
not been examined further. In-depth immunoelectron microscopic examination of C.
trachomatis-infected polarized HEC-1B cells at 48 hours post-infection (hpi) revealed
the presence of chlamydial antigens localizing along the exterior of the inclusion and, in
some cases, within host cell cytosolic tracts morphologically distinctive of the ER.
Second affinity gold-conjugated antibodies detected primary anti-IncA polyclonal
antibodies, anti-LPS polyclonal antibodies and anti-MOMP monoclonal antibodies
localizing their respective antigens adjacent to the chlamydial inclusion membrane,
frequently appearing in tracts of ER (Fig. 4.1A-C). Similarly, the ER luminal markers
BiP/GRP78, ERp57, and calnexin all displayed a propensity for labeling at or near the
inclusion membrane region and were often observed in areas positive for chlamydial
LPS, MOMP, and IncA (Fig. 4.2). Importantly, additional double-labeling experiments
revealed no co-localization between chlamydial LPS, MOMP, and IncA with host
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markers for endosomes (EEA-1), lysosomes (LAMP1), cis-Golgi (GM130), or
mitochondria (MTC02) (data not shown).

Figure 4.1 Ultrastructural Localization of Chlamydial Antigens to the Host Cell
Endoplasmic Reticulum (ER). HEC-1B cells infected with C. trachomatis E for 48 hr
were prepared for post-embedding immunoelectron microscopy. (A-C) Chlamydial
IncA (A), LPS (B), and MOMP (C) were detected in host cell cytosolic tracts
characteristic of ER (arrowheads). Scale bars, 500 nm.
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Figure 4.2 Ultrastructural Co-Localization Between Chlamydial Antigens and Host Cell
ER Markers. HEC-1B cells infected with C. trachomatis E for 48 h were prepared for
post-embedding immunoelectron microscopy. (A-D) Co-localization between
chlamydial LPS (5nm gold; arrow) and the ER markers BiP/GRP78 (A and B), calnexin
(C), and Erp57 (D; 15nm gold; arrowheads; magnified in insets). Scale bars, 200 nm.
(E) Co-localization between chlamydial IncA (5nm gold) and the ER marker BiP/GRP78
(15nm gold; arrowhead, magnified in inset). Scale bar, 200 nm. (F) Co-localization
between chlamydial MOMP (5nm gold; arrow) and the ER marker calnexin (15nm gold;
arrowhead). Scale bar, 200 nm.
A Potential Mechanism of Delivery for Chlamydial Antigens to the Host Cell ER
Previous studies in our laboratory noted numerous vesicles exterior to the chlamydial
inclusion within the host cell cytosol in infected HEC-1B cells; these vesicles contained
chlamydial outer membrane vesicles (OMV) that labeled positive, by immunoelectron
microscopy, for several chlamydial antigens including MOMP and LPS (Giles et al.,
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2006). It was discovered that these vesicles originated by eversion or pinching off from
the inclusion membrane as they contained IncA. Because these vesicles were also
prevalent in the present study (Fig. 4.3), it was hypothesized these chlamydial antigen
OMV-containing (Fig. 4.3B and C) everted inclusion membrane vesicles (Fig. 4.3A,
arrowheads) might traffic to and fuse with the ER, thereby delivering the cytosolic
protease-protected antigens directly into the ER. To test this hypothesis, cytosolic
vesicles and secretory components were isolated from infected cells and examined for
co-localization with chlamydial IncA, MOMP, and LPS.

Figure 4.3 Ultrastructural Identification of Extra-Inclusion Vesicles in C. trachomatisInfected Human Endometrial Epithelial Cells. (A) The appearance of extra-inclusion
vesicles within the infected HEC-1B cell cytosol at 48 h. Some vesicles were observed
everting from the inclusion (arrowheads). Scale bar, 2 µm. (B and C) The contents of
the extra-inclusion vesicles (arrowheads) resemble outer membrane blebs found within
the inclusion. Scale bars, 500 nm.
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Co-localization of Chlamydial Antigen and ER Markers Following ER Isolation
Organelles of the secretory pathway were isolated from uninfected control and C.
trachomatis-infected HEC-1B cells using Iodixanol (Optiprep) gradients and the
resultant fractions were subjected to Western blot analysis by probing with antibodies to
the ER and chlamydiae (Fig. 4.4). Several ER membrane (TAP-I and Sec61) and
lumenal (calnexin, ERp57, PDI, and CD1d) markers positively labeled fractions 7-10,
defining the ER-containing fractions. These results match those of Plonne et al. (1999),
who found, through enzymatic assays, the ER to occupy the same area in the gradient.
The bulk of chlamydial LPS, MOMP, and IncA was found in the ER-containing fractions.
The positive control markers for intact EB and RB, chlamydial histone protein HC1 and
heat shock protein 60-1, were detected only in the infected cell lysate (Fig. 4.4, column
L), indicating that the presence of LPS, MOMP, and IncA in fractions 7-10 could not be
attributed to contaminating whole chlamydial forms. Indeed, probing of the
mitochondrial (12,000g) pellet yielded reactivity to all chlamydial antibodies (data not
shown), suggesting that EB and RB were pelleted with the mitochondria, which is
routine.
Fractions 1 and 2, which were slightly positive for chlamydial LPS, MOMP, and IncA
(Fig. 4.4), were determined to be membranes incompletely removed in previous steps of
the protocol, as evidenced by the presence of multiple membrane proteins (Integrin α2,
TGN38, and LAMP1) from various organelles (data not shown). Chlamydial
membranes from RB and/or the inclusion membrane would account for the presence of
LPS, MOMP, IncA, and CT223, another inclusion membrane protein, detected in
fractions 1 and 2 but absent in other fractions (data not shown). In our gradients, the
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cis-Golgi was consistently found in fractions 1-4, whereas the trans-Golgi extended into
fractions 5-7 (data not shown). Hence, there was an expected slight overlap between
trans-Golgi and the ER/chlamydial antigen-containing fractions 7-10.

Figure 4.4 Western Blot Analysis of Gradient Fractions With Antibodies Specific for ER
Components and Chlamydial Antigens From C. trachomatis-Infected HEC-1B Cells.
Serial fractions were pooled and ten micrograms of protein was separated on 4-12%
gradient gels using SDS-PAGE prior to immunoblotting. The positive control ER
markers calnexin, PDI, Sec61, Erp47, and TAP I displayed strong detection in fractions
7-10, defining the ER-containing fractions. CD1d, an MHC-like glycoprotein resident of
the ER, was found primarily in fractions 9-12. Chlamydial MOMP, LPS, and IncA were
strongly detected in the ER-containing fractions. The positive control chlamydial
markers HC1 and cHsp60-1, known to be restricted to intact chlamydial EB and RB,
were only detected in the infected cell post-nuclear lysate (L).
Supporting the hypothesis that these chlamydial antigens are creating immunological
consequences is the fact that fractions 7-10 represent smooth ER, where antigens are
transported into and loaded onto MHC-I molecules. It is thought that fractions 13 and
14, which were positive for MOMP, IncA, and CT223, represent a subfraction of rough
ER, as shown by Plonne et al. (1999). The presence of IncA and CT223 in these
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fractions may further support the idea, put forth by Luo et al. (2007) that inclusion
membrane localization is better predicted by ER co-localization than by bi-lobed
hydrophobic motifs, as was the case for C. pneumoniae. These fraction isolation data
strongly support the presence of important chlamydial antigens in the ER of infected
endometrial cells.

Examination of the Isolated ER/Chlamydial Antigen-Containing Fractions by TEM
For additional confirmation that the isolated gradient fractions 7-10 were, indeed, ER
vesicles containing chlamydial antigen, pooled gradient fractions were viewed by
negative stain and processed for post-embedding immunoelectron microscopy. The
crude microsomal fraction, representing the sum of all gradient fractions isolated from
C. trachomatis-infected HEC-1B cells, contained numerous vesicles ranging from 100500 nm in size (Fig. 4.5A), representing a typical vesicle preparation previously
described (Plonne et al., 1999). Immunostaining of the crude microsomal fraction
revealed vesicles co-labeling for chlamydial LPS and Sec61, an ER membrane marker
(Fig. 4.5A, inset). Closer examination of the ER/chlamydial antigen-containing fractions
8-10 by double-label immunoelectron microscopy revealed a subset of vesicles that
displayed co-localization between chlamydial LPS, MOMP, and IncA and a variety of
ER markers (Fig. 4.5B-G). An LPS polyclonal antibody was detected within vesicles colabeling for the ER luminal markers BiP/GRP78, Erp57, and calnexin (Fig. 4.5B-D). A
MOMP monoclonal antibody also localized to vesicles containing calnexin (Fig. 4.5E).
Chlamydial IncA was associated with vesicles positive for calnexin and Erp57 (Fig. 4.5F
and G). All vesicles exhibiting co-localization were approximately 100-200nm in size, a
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morphological trait characteristic of isolated microsomes containing vesicles derived
from fragmented ER (Czichi and Lennarz, 1977).

Figure 4.5 Examination of ER/Chlamydial Antigen-Containing Isolated Density Gradient
Fractions by TEM. (A) Representative negative stain of the crude ER microsomal
fraction from C. trachomatis-infected HEC-1B cells. Scale bar, 500 nm. The inset
represents double-label immunogold electron microscopy co-localizing chlamydial LPS
(5nm gold) and the ER membrane marker Sec61 (15nm gold) to an ER microsomal
vesicle. Scale bar, 100 nm. (B-D) Double-label immunogold electron microscopy
revealed co-localization between chlamydial LPS (5nm gold) and three ER markers
(15nm gold): BiP/GRP78 (B), Erp57 (C), and calnexin (cal; D). Scale bars, 100 nm.
(E) Co-localization between chlamydial MOMP (5nm gold) and the ER marker calnexin
(15nm gold). Scale bar, 100 nm. (F and G) Co-localization between chlamydial IncA
(5nm gold) and the ER markers (15nm gold) calnexin (cal; F) and Erp57 (G). Scale bar,
100 nm. Chlamydial antibodies were detected with 5nm-gold-conjugated secondary
antibodies. ER antibodies were detected with 15nm-gold-conjugated secondary
antibodies.
Because IncA serves as a positive control for the everted inclusion membrane
vesicles containing chlamydial LPS and MOMP antigens, our results strongly support
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the original findings of Delevoye et al. (2004) for IncA-SNARE-mediated fusion with the
ER, thereby providing a conduit for deposition of chlamydial antigens.

Ultrastructural Association Between Chlamydial LPS and CD1d, a Lipid Antigen
Presenting MHC-Like Glycoprotein
The localization of chlamydial LPS in the ER of infected cells was a surprising finding.
Exogenous LPS binds to LPS-binding protein (LBP) prior to engaging CD14 on the host
cell surface and activating the TLR4 pathway. However, the fate of intracellular LPS is
limited to isolated studies with incomplete conclusions. CD1d molecules, which present
lipids derived from intracellular sources, specifically signal natural killer T (NKT) cells
(Van Kaer, 2007). CD1d is proposed to bind endogenous lipid, such as
phosphatidylinositol, within the ER and traffic through the secretory pathway to the
plasma membrane, where CD1d-restricted T cell recognition can occur. The unusually
long fatty acyl chains (C22-C24 vs C12-C14; Heine et al., 2003) of chlamydial LPS,
coupled with the deep antigen-binding groove properties of CD1d, led to an
investigation on potential interaction between chlamydial LPS and CD1d. It was first
determined that HEC-1B cells do possess CD1d following Western blot of uninfected
HEC-1B lysate (data not shown). Immunoelectron microscopy of C. trachomatisinfected HEC-1B cells revealed co-localization between chlamydial LPS and CD1d at
the inclusion membrane (Fig. 4.6A-C) and in tracts and vesicular structures within the
host cell cytosol (Fig. 4.6D and E). Following ER isolation, examination of ERcontaining fractions by post-embedding immunoelectron microscopy indicated colocalization of chlamydial LPS and CD1d within the same vesicles (Fig. 4.6F and G).
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These vesicles conformed to microsomal size (100-200nm) and matched the
morphology of CD1d-positive vesicles from ER-containing fractions of uninfected HEC1B cells (data not shown). These observations strengthen the co-localization of
chlamydial LPS and CD1d to the ER, confirming the findings by Kawana et al. (2007,
Fig. 5) and suggest an association between chlamydial LPS and CD1d during infection.

Figure 4.6 The MHC-Like Glycolipid-Binding Protein CD1d Co-Localizes with
Chlamydial LPS in the ER during C. trachomatis-Infection of Polarized Human
Endometrial Epithelial Cells. (A-C) Co-localization between CD1d (15nm gold) and
chlamydial LPS (5nm gold) at the inclusion membrane (arrowheads; magnified in
insets). Scale bars, 200 nm. (D and E) Co-localization between CD1d (15nm gold)
and chlamydial LPS (5nm gold) within vesicles present in the infected host cell cytosol
(arrowheads; magnified in insets). Scale bars, 200 nm. (F and G) Co-localization
between CD1d (15nm gold) and chlamydial LPS (5nmgold) within vesicles isolated from
ER-containing fractions (see Fig. 5). Scale bars, 100 nm. CD1d antibodies were
detected with 15nm-gold-conjugated second-affinity antibodies. LPS antibodies were
detected with 5nm-gold-conjugated secondary antibodies.
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Discussion
Many studies have implicated the exocytic pathway with the host cell niche harboring
Chlamydia (Hackstadt et al., 1997). Although most research has centered around the
Golgi, there have been some intriguing observations hinting towards interaction
between Chlamydia and the ER, an association now recognized as important for other
intracellular microorganisms (Roy et al., 2006). Wylie et al. (1997) have shown that the
inclusion membrane acquires ER composition in the form of host cell phospholipids.
Majeed et al. (1999) observed the ER proteins SERCA2 and calreticulin to be closely
associated with chlamydial inclusions using confocal microscopy. Another group of
investigators not only observed similar labeling of calreticulin around inclusions but also
reported decreases in calreticulin labeling when infected cells were exposed to excess
amino acids or the autophagic inhibitor 3-MA (Al-Younes et al., 2004). Because these
events can occur early-mid developmental cycle, it is tempting to speculate that the
juxtaposition of the ER with the inclusion membrane is due to active recruitment by
Chlamydia rather than the result of chlamydial inclusion expansion within the host cell
resulting in organelle crowding around the inclusion. Most intriguing are the recent
reports of chlamydial inclusion membrane proteins (IncA, Cpn0146 and Cpn0147) colocalizing with the ER when expressed via transgenes in HeLa cells (Delevoye et al.,
2004; Luo et al., 2007). Our data strengthen and extend the observations of
involvement of the ER during chlamydial infection by revealing that: (i) several ER
markers consistently labeled proximal to the inclusion membrane; (ii) chlamydial LPS,
MOMP and IncA were localized by immunoelectron microscopy to the ER of infected
host cells, a finding reinforced by co-localization of chlamydial and ER markers; (iii)
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Western analysis of fractions from density gradient separation of the infected host cell
secretory compartment vesicles illustrated the presence of chlamydial LPS, MOMP, and
IncA within ER-containing fractions; (iv) chlamydial antigens and ER markers were colocalized to identifiable ER microsomes fractions; and (v) chlamydial LPS was
discovered to co-localize with CD1d, a lipid antigen-presenting molecule, both within the
infected host cell and on ER microsomes from density gradient fractions. Thus, it is
apparent that chlamydial antigens can access the ER of infected host cells.
From our current understanding of chlamydial pathogenesis, there are three ways by
which chlamydial proteins could traverse the inclusion and reach the ER of infected
epithelial cells. Zhong and colleagues (2000, 2001) were the first to show that a
chlamydial protease-like activity factor (CPAF) appeared in the cytosol of infected cells
and was responsible for degrading the transcription factors RFX5 and USF1, which
resulted in downregulation of MHC-I and MHC-II surface expression. Subsequently, an
apoptosis-modulating chlamydial protein, CADD [Chlamydial protein Associating with
Death Domains], was also found in the infected cell cytosol (Stenner-Liewen et al.,
2002). How these proteins are transported across the inclusion membrane is unknown.
Secondly, like Salmonella (Ochman et al., 1996), intracellular chlamydiae, via T3S
machinery, can inject effector proteins into the host cytosol (Fields et al., 2005; Ho and
Starnbach, 2005; Lugert et al., 2004). Inhibition of T3S as well as heterologous
expression of IncA in the ER of infected cells can, in some situations, interfere with
progression of the chlamydial developmental cycle (Delevoye et al., 2004; Muschiol et
al., 2006), underscoring the significance of protein secretion during infection. In these
cases, any chlamydial protein reaching the host cytosol would be presumed subject to
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classical MHC-I processing and presentation, involving chlamydial protein
ubiquitination, proteasomal processing, and return of the peptides to the lumen of the
ER via ATP-dependent TAP transport for MHC-I loading. Thirdly, as referred to in this
study, the eversion of inclusion membrane-derived vesicles, containing chlamydial outer
membrane blebbed vesicles positive for LPS, MOMP, and IncA (Giles et al., 2006).
Because IncA served as the inclusion membrane marker for the pinched-off vesicles,
we hypothesized that these vesicles could, using the SNARE-like properties of IncA
(Delevoye et al., 2004), fuse with the ER and deliver chlamydial antigens into this
compartment. This delivery of presumably native chlamydial protein into the ER would
require intra-ER peptide trimming (Paz et al., 1999) and/or Sec61/chaperone
retrotranslocation into the cytosol for proteasomal degradation (Tirosh et al., 2003;
Wiertz et al., 1996) for antigen presentation to occur.
An alternative consequence of LPS, MOMP, and IncA reaching the ER could be
another cellular response involving ER stress. Known as the unfolded protein response
(UPR), this phenomenon can be induced by physiological conditions known to cause
protein misfolding, such as metabolite deprivation, expression of mutant proteins and
viral infection (Lin et al., 2007). LPS has further been identified as an initiator of UPR
(Kozlov et al., 2007). Affected host cells respond by activating ER stress pathways
involving translational repression and chaperone induction (Schroder and Kaufman,
2005). A key indicator for ER stress is enhanced expression of the glucose regulated
protein BiP/GRP78. Interestingly, when we compared uninfected and infected
BiP/GRP78 protein expression by Western blot, there existed a noticeable increase in
infected cells (data not shown). In the current study, the localization of LPS, MOMP,
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and IncA to the ER, coupled with the increase of BiP/GRP78 during infection, suggests
that the chlamydiae-infected cell may be subjected to ER stress.
Natural C. trachomatis infection occurs in genital epithelial cells, which are capable
of initiating and sustaining innate immune responses (Quayle, 2002). Epithelial cells
typically express high levels of MHC-I compared to MHC-II, suggesting an important
role for CD8+ T cells in the recognition of C. trachomatis-infected genital mucosa.
Indeed, antigen-specific CD8+ T cells are recruited to the site of chlamydial infection,
can help limit infection and confer protection against Chlamydia challenge in mice
(Igietseme et al., 1994; Roan and Starnbach, 2006). Several intracellular bacteria elicit
the MHC-I processing pathway, including Salmonella, Mycobacteria, Listeria and
Toxoplasma (Chiplunkar et al., 1986; Flynn et al., 1990; Gubbels et al., 2005; Zwickey
and Potter, 1999). The presence of chlamydial protein either in the host cell cytosol or
integrated into the inclusion membrane does not go unnoticed, as indicated by the
identification of specific antigen epitopes that are T cell targets of cell-mediated immune
response (Fling et al., 2001; Gervassi et al., 2004; Kuon et al., 2001; Starnbach et al.,
2003). MOMP cytotoxic T lymphocyte epitope clusters have been identified and
MOMP-specific CD8+ T cells can be detected during Chlamydia infection (Kim and
DeMars, 2001). IncA recently gained recognition as an important antigen as reflected by
human antibody production and detection of IncA antigen in patient urine (Tsai et al.,
2007). Our observations of chlamydial antigens within the ER of infected cells at middevelopment suggest involvement of the MHC-I pathway, the accessibility of which may
be direct considering the strong localization of multiple ER markers in close proximity to
the inclusion membrane.
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LPS has been frequently observed on the plasma membrane of infected host cells
and, in some cases, on the surface of neighboring uninfected cells (Campbell et al.,
1994; Karimi et al., 1989; Wyrick et al., 1999). It has been proposed that, as a
consequence of LPS incorporation into the plasma membrane and the resultant
decreased fluidity, the infected cell is refractory to cytolysis from a complementmediated mechanism or from natural killer or T cell granzymes and perforins (Wilde et
al., 1986). Despite its low endotoxic potency, chlamydial LPS can stimulate
proinflammatory cytokine secretion by macrophages (Ingalls et al., 1995) and can signal
via TLR2 and TLR4, molecules recently shown to be transcriptionally upregulated and
recruited to the inclusion during Chlamydia infection (Erridge et al., 2004; Heine et al.,
2003; Mackern-Oberti et al., 2006; O'Connell et al., 2006).
While numerous studies have examined the immunological effects of exogenous
LPS, only a few studies have addressed the handling of LPS released intracellularly.
Salmonella has been shown to release LPS from its vacuolar compartment into vesicles
present in the host cell cytosol (Garcia-del Portillo et al., 1997), and intracellular
recognition of LPS has been reported in epithelial cells (Girardin et al., 2001; Hornef et
al., 2003). CD1d presents endogenous lipid antigen to natural killer T (NKT) cells.
Bilenki et al. (2005) reported evidence for the involvement of NKT cells during
chlamydial infection in mice. Their data suggested that CD1d-restricted NKT cells can
affect the immune response to Chlamydia infection and play a role in pathological
outcome. CD1d was detected in our HEC-1B cells, confirming other studies
demonstrating that genital epithelial cells express CD1d (Sallinen et al., 2000).
Furthermore, we observed by Western blot the same pattern of CD1d degradation
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during C. trachomatis infection reported by Kawana et al. (2007) (data not shown).
Because CD1d possesses deep independent hydrophobic pockets for anchoring long
fatty acyl chains, such as the C22-C24 of chlamydial lipid A, and is able to recognize
antigen intracellularly, we hypothesized that chlamydial LPS, with its unique chemical
structure and proclivity to escape from the inclusion, may provide an accessible target
for lipid antigen recognition by host cells. The immunoelectron microscopic localization
of CD1d and LPS in the ER of host cells indicates accessibility but not recognition. If,
indeed, LPS can be recognized and/or modified by CD1d, then these data suggest that
host cells may use endogenous CD1d-antigen processing.
Interestingly, we also observed a few cases where CD1d and LPS were co-localized
at the plasma membrane (data not shown). The extracellular release of LPS, coupled
with its propensity to integrate into membranes, introduces an intriguing scenario of
cross-presentation, wherein chlamydiae-infected cells regurgitate LPS extracellularly
where it could be incorporated into the plasma membrane of neighboring uninfected
cells and subsequently endocytosed, providing the opportunity for endosomallyacquired antigen presentation by CD1d. So although CD1d molecules are decreased
on the host cell surface of C. trachomatis-infected cells (Kawana et al., 2007), the
release of LPS during infection may result in CD1d-restricted T cell recognition of
uninfected epithelial cells. Depending on the level of LPS escape, such an NKT cell
response could contribute to the chronic nature of inflammation in chlamydial infection,
not to mention create an environment of immune mediators that induce chlamydial
persistence.
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In summary, our data support a greater role for the ER during chlamydial infection in
polarized human endometrial epithelial cells. Considering the escapability and
immunogenic properties possessed by chlamydial LPS, MOMP, and IncA, the trafficking
of chlamydial lipids and proteins to the ER is likely to create ER stress, or alterations in
some ER functions, and/or provide antigens for MHC-I and CD1d presentation. Whether
or not the results serve a protective role or an immuno-destructive role for chlamydiae is
yet to be determined.

Experimental Procedures
Cell Culture Systems and Growth of Chlamydia
The human endometrial carcinoma subclone 1B cell line (HEC-1B; HTB-113; ATCC,
Manassas, VA) was maintained at 37°C in Minimal Essential Medium (MEM) containing
Hank’s salts (Gibco, Grand Island, NY) supplemented with 10% fetal calf serum
(Hyclone, Logan, UT) and 2mM glutamine. The HEC-1B cells were grown in a
polarized manner in two culture systems: (i) on extracellular-matrix (ECM) coated filters
(BioCoat Matrigel Invasive Chambers, 0.3 cm2, BD Biosciences, San Jose, CA)
cultivated in Dulbecco’s modified Eagle MEM (Gibco) supplemented with 10% fetal calf
serum and 10 mM HEPES, pH 7.3 (DMEM) and maintained at 35°C in an atmosphere
of 5% carbon dioxide, and (ii) on collagen-coated DEAE-Sephadex beads (Cytodex 3
microcarrier beads; Sigma, St. Louis, MO) in 500mL spinner flasks as described
previously (Guseva et al., 2007).
A human urogenital isolate C. trachomatis E/UW-5/CX was used in these
experiments. Standardized inocula of C. trachomatis infectious EB were prepared from
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HEC-1B cells grown on Cytodex microcarrier beads. Progeny EB were harvested,
titrated for infectivity, and stored at -80°C.

Chlamydial Infection of Polarized Cells
Polarized HEC-1B cell monolayers on ECM-coated filters were inoculated with C.
trachomatis EB by passive adsorption with a titer of crude stock diluted to a
concentration demonstrated to yield at least 80% infected cells. The same crude stock
of infectious EB was used to inoculate polarized HEC-1B cells grown on beads in
suspension. In both culture systems, the duration of the C. trachomatis developmental
cycle was 52h. For experiments in the present study, host cells were infected for 48h in
the absence of antibiotics.

Endoplasmic Reticulum Isolation
Major intracellular organelles of the secretory pathway, including Golgi, smooth ER, and
rough ER were separated using an Endoplasmic Reticulum Isolation Kit (Sigma), based
upon a protocol originally published by Plonne et al. (1999). Briefly, uninfected and C.
trachomatis-infected HEC-1B cells grown in bead culture were dounce homogenized
and subjected to a series of centrifugation steps to pellet the beads, cell nuclei,
mitochondria, and microsomes. Careful analysis of each discarded fraction ensured
removal of nuclei, mitochondria, endosomes, lysosomes, and the bulk of membranes.
In infected cells, removal of intact EB and RB was confirmed by (i) Western blot
antibody probing for histone protein 1 (HC1) and heat shock protein 60-1 (cHsp60-1)
and (ii) the absence of chlamydial forms in the fractions processed for transmission
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electron microscopy (TEM). The microsomal fraction was separated into Golgi, smooth
ER and rough ER using the gradient medium Iodixanol (Optiprep). Sixteen 500µl
fractions were collected from the top of the gradient downward with a syringe.

Western Immunoblotting
Fractions from the Iodixanol gradients were solubilized in Laemmli buffer with protease
inhibitors (Sigma) and equal amounts of protein were determined by the RC/DC assay
(Bio-Rad, Hercules, CA). Fractions were paired and proteins were separated by SDSPAGE using 4%-12% Bis-Tris gradient gels and transferred to polyvinylidene difluoride
(PVDF) membranes for Western blot analysis. The membranes were blocked with 5%
skim milk in phosphate-buffered saline (PBS) before primary antibody incubation.
Horseradish peroxidase-conjugated goat anti-mouse, goat anti-rabbit and rabbit antigoat second-affinity antibodies (Pierce Biotechnology, Rockford, IL) were used prior to
chemiluminescent detection (Pierce). Standard protein size markers (Bio-Rad) were
used to confirm molecular weights of target proteins.

Antibodies
Chlamydial markers used in this study included (1) monoclonal antibodies directed
against IncA (a kind gift from Dr. Dan Rockey, Oregon State University, Corvallis, OR),
MOMP (Santa Cruz Biotechnology, Santa Cruz, CA) and LPS (Virostat, Portland, ME);
(2) rabbit polyclonal antibodies directed against IncA (via Dr. Rockey) and LPS (Cortex
Biochem, San Leandro, CA) and (3) goat polyclonal antibodies directed against MOMP
(Biodesign International, Saco, ME). Eukaryotic host cell markers used in this study
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included (1) monoclonal antibodies directed against LAMP1 (BD Biosciences), calnexin
(Chemicon International, Temecula, CA), ERp57 (Novus Biologicals, Littleton, CO) and
BiP/GRP78 (BD Biosciences) and (2) rabbit polyclonal antibodies directed against
calnexin (a kind gift from Dr. Daniel Hebert, Yale University, New Haven, CT), Sec61
alpha (Affinity Bioreagents, Golden, CA), ERp57 (Affinity Bioreagents), TGN38 (Santa
Cruz), TAP I (Novus Biologicals), and CD1d (Santa Cruz).

Transmission Electron Microscopy
The C. trachomatis-infected HEC-1B cell monolayers grown on filters were processed
and embedded in Epon-araldite for high contrast or in Lowicryl resin (Polysciences,
Warrington, PA) for immunoelectron microscopy (Giles et al., 2006). The crude
microsomal pellet was resuspended in isolation buffer (Sigma) and examined by
negative staining. A volume of 5µl was pipetted onto formvar-coated copper grids and
allowed to adhere for 2 min before excess sample was removed by touching the grid
with filter paper. The grids were washed three times with 10µl distilled water and airdried. Then, 10µl of 2% phosphotungstic acid was pipetted onto each grid, which was
allowed to stand for 30 sec before the excess was removed using filter paper. The
Iodixanol gradient fractions were examined in resin enrobed and processed sectioned
material. For section preparation, gradient fractions 8-10 and 12-14 were combined,
mixed with 5 vol of PBS and pelleted by centrifugation at 150,000g for 90 min at 4°C in
a Sorvall T-1270 rotor. The pellets were fixed for 1 h at 4°C in 2%
paraformaldehyde/0.05% glutaraldehyde in 0.1M Sorenson’s buffer, agar enrobed in 3%
SeaKem agarose and samples were infiltrated, processed embedded in Lowicryl, and
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polymerized by UV light. Ultrathin sections were prepared using a Reichert Ultracut S
microtome (Leica Microsystems, Inc., Bannockburn, IL). For immunoelectron
microscopy, 80-nm-sections were blocked with 1% ovalbumin/0.01M glycine in PBS for
5 min and subsequently incubated with the primary antibody for 40 min at 37°C.
Sections were washed with PBS and probed with the appropriate 5 or 15nm colloidal
gold-conjugated second-affinity antibody (Amersham Biosciences, Piscataway, NJ) for
30 min at 37°C. Sections were washed with PBS and distilled water prior to staining
with 4% uranyl acetate prepared in 50% ethanol. For double labeling, the second
primary antibody was administered following the last PBS wash and the procedure was
repeated. All labeling experiments were conducted in parallel with controls using an
irrelevant primary antibody or a gold-labeled second-affinity antibody alone to determine
background cross-reactivity. Thin sections on grids were examined in a Phillips Tecnai10 electron microscope (FEI) operated at 80kV.
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CHAPTER 5
CONCLUSION

The majority of patients with initial chlamydial infections are asymptomatic. This is
attributed to the growth of chlamydiae in an unobtrusive intracellular vacuolar inclusion
niche in infected genital epithelial cells. Moreover, the ascending sequealae from
urethritis or cervicitis are immune-mediated. Thus, a major gap exists in our knowledge
between chlamydial antigen trafficking and the triggers that signal the innate and
subsequent adaptive immune responses.
Nearly 3 decades have passed since the first observation of a chlamydial antigen,
LPS, localized exterior to the inclusion prior to the release of infectious progeny from the
host epithelial cell at the end of the developmental cycle (Richmond and Stirling 1981).
Only in the last 10 years have studies surfaced with further evidence of the presence of
chlamydial proteins within the cytosol of infected cells (Zhong and others 2000; StennerLiewen and others 2002; Lugert and others 2004; Fields and others 2005; Ho and
Starnbach 2005). Previous data from our laboratory identified chlamydial LPS and
MOMP within vesicles exterior to the inclusion; these antigens were subsequently
observed on the host cell surface and released extracellularly (Paul and others 1997;
Wyrick and others 1999). Indeed, the premature escape of chlamydial antigens may
influence antigen trafficking and presentation by the host cell and contribute to the
prolonged inflammatory response typical of chlamydial infections. The primary goal of
the studies described herein was to further characterize by high resolution immuno-
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electron microscopy the vesicle-mediated route of chlamydial antigen escape and to
track these antigens to potential host cellular destination(s).
The first study involved an ultrastructural examination of the origin and content of the
chlamydial antigen-containing vesicles present in the host cell cytosol of C. trachomatisinfected polarized endometrial epithelial cells (Giles and others 2006). Extensive
analysis of electron micrographs, generated from samples processed in two distinct
resins (Epon for high contrastand Lowicryl for antigen detection), revealed the existence
of extra-inclusion vesicles within azithromycin-exposed and -unexposed chlamydiaeinfected cells (Figs 2.1 and 2.2). Closer observation uncovered the similarity between
chlamydial outer membrane blebs within the inclusion and the material occupying the
extra-inclusion vesicles, a finding justified when these vesicles were visualized in the act
of pinching off from the chlamydial inclusion (Fig 2.2). Post-embedding labeling
immunoelectron microscopy localized three chlamydial inclusion membrane proteins
(IncA, IncF, and IncG) to (i) RB outer membranes, (ii) the inclusion membrane, (iii)
regions of the inclusion membrane protruding into the host cell cytosol, (iv) the surface
of extra-inclusion vesicles, and (v) on membranous blebs both inside the inclusion and
within extra-inclusion vesicles (Fig. 2.3). The extra-inclusion vesicles were devoid of
multiple Golgi-specific markers, differentiating them from Golgi vesicles (Fig. 2.4).
Finally, a survey of the localization of the three chlamydial Hsp60 homolog proteins
revealed confinement of cHsp60-1 to RB within the inclusion, but cHsp60-2 and
cHsp60-3 were found within the extra-inclusion vesicles and on the host cell surface,
suggesting a selective process governing escape of chlamydial antigens (Fig 2.5). This
study added extra-inclusion vesicles to known and suspected methods of chlamydial
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antigen escape, including release of chlamydiae at the end of the developmental cycle,
the secretion of chlamydial effectors by Type III secretion or by autotransporters, and
the appearance of small vesicles exterior to the inclusion following induction of
persistence by penicillin exposure. Therefore, emphasis was placed on the potential for
these escaped antigens to trigger immune mechanisms, perhaps within the nonimmune host epithelial cells.
In a separate study, peptide antisera specific for each of the three chlamydial Hsp60
homologs were used for immunolabeling transmission electron microscopy to examine
their iron responsiveness. For generation of a quantitative measure reflecting
qualitative TEM images, multiple (>50 per condition per cHsp60 homolog) micrographs
were obtained and square fields of constant size were randomly generated prior to gold
particle counting. Comparison of these counts, using the Student’s two-tailed t test,
revealed an enhanced expression of cHsp60-2 in response to iron deprivation (Figure
3.3) (LaRue and others 2007). These results strengthened the notion that cHsp60-2
deserves consideration as a potential mediator of immune-mediated pathology,
especially when coupled with the previous finding of cHsp60-2 escaping the inclusion
via inclusion membrane-derived vesicles.
A deeper investigation of the trafficking of chlamydial antigens within infected host
cells led to experiments designed to reveal the specific destination(s) of those antigens.
The focus was placed on normally infected cells as opposed to azithromycin-exposed
infected cells in order to mimic more accurately natural infection. Immunoelectron
microscopic detection of major chlamydial antigens within C. trachomatis-infected
polarized endometrial epithelial cells revealed localization of chlamydial MOMP, LPS,
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and IncA within the host cell endoplasmic reticulum (ER) (Figure 4.1). These findings
were corroborated with double-labeling experiments demonstrating co-localization
between chlamydial antigens and multiple ER markers (Figure 4.2). Stressing the
importance of vesicles escaping the chlamydial inclusion and serving as a delivery
mechanism for antigens, an electron micrograph composite (Figure 4.3) conveyed the
natural occurrence of these vesicles at mid-development of chlamydiae during infection.
These ultrastructural observations prompted attempts to isolate the ER from infected
cells using density gradient centrifugation. Upon separation of the organelles of the
infected host cell secretory pathway, it was found that chlamydial antigens occupied
fractions positive for various ER luminal and membrane markers (Figure 4.4) but not
with markers specific for endosomes, lysosomes, and Golgi. When these fractions were
negatively stained and/or processed for double label immunoelectron microscopy, the
vesicle population resembled ER microsomes and these microsomes co-labeled for ER
and chlamydial markers (Figure 4.5).
The unexpected presence of chlamydial LPS in the host cell ER led to the
hypothesis that the glycolipid-binding MHC-like protein CD1d, a resident of the ER,
could provide a route of LPS recognition and antigen presentation. Postembedding
immunoelectron microscopy of C. trachomatis-infected polarized epithelial cells and
isolated ER microsomes during infection revealed co-localization between chlamydial
LPS and CD1d (Figure 4.6). In chlamydiae-infected cells, this association was
observed at the inclusion membrane and in small vesicles within the host cell cytsol,
and the isolated ER microsomes were shown to contain both chlamydial LPS and
CD1d. Taken together, these studies suggest trafficking, perhaps via inclusion
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membrane-derived vesicles, of chlamydial antigens to the ER of host epithelial cells.
The results also hint towards a potential method of endogenous chlamydial LPS
recognition and antigen presentation as evidenced by LPS and CD1d co-localization
within infected epithelial cells.
Collectively, the findings from these studies emphasize the escape of chlamydial
antigens from the inclusion as a contributor to the local immune response. Whether by
a novel mechanism of inclusion vesicle formation or by other means such as Type III
secretion or autotransportation, chlamydial antigens were shown to traffic to the host
cell ER and plasma membrane and be released extracellularly. Such placement of
antigens may elicit host innate and adaptive immune responses that could either limit
the infection or exacerbate the inflammatory processes associated with infection.
Attempts to further define the “cellular paradigm of chlamydial pathogenesis” (Stephens
2003) demand a better understanding of the infected human host epithelial cell’s
immune capabilities. Then, by examining intracellular molecular interactions of the
human epithelial cell and chlamydiae, the nature of immune response may be
determined.
The epithelial cell, as host to C. trachomatis, plays a crucial role in determining the
outcome of infection. Human genital epithelia display a characteristic polarized
structure consisting of basolateral and apical plasma membrane domains. This threedimensional orientation provides organization for efficient intracellular trafficking as well
as creating directionality for extracellular signaling. Only when polarized can epithelial
cells form intercellular tight junctions that create a selective barrier defense against
mucosal pathogens. In addition to serving as a physical barrier, epithelial cells
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participate in other innate immune functions such as recognition of pathogen-associated
molecular patterns (PAMPs), production and release of antimicrobial mediators, and
secretion of cytokines and chemokines. It is these attributes that make epithelial cells a
vital component in chlamydial biology, pathogenesis and infection. Previous in vitro
studies have already emphasized the differences in chlamydial development when
using non-polarized versus polarized cell culture. Among these findings are variations
in EB infectivity, EB entry and exit, developmental cycle progression, chlamydial
persistence, hormone responsiveness, antibiotic reactivity and population of
inflammatory response cells. The distinctions between non-polarized and polarized cell
culture strongly suggest that in vitro chlamydial infection using polarized cell culture
mimics more closely in vivo chlamydial infection as well as the subsequent host cellular
response to infection. Hence, justifying the use of polarized cells in the present studies.
It is expected that genital epithelial cells will continue to reveal recognition molecules
that play a role in pathogen detection and clearance. As evaluated in Chapter 4,
molecules such as CD1d could be instrumental in detecting chlamydial lipids both within
the infected cell and those released extracellularly. Another recognition molecule
worthy of consideration in chlamydial infections is Nod1, a member of intracellular
proteins with homology to plant disease-resistant gene products. Nod1 has been
shown to confer responsiveness and binding capability to microbial LPS (Inohara and
others 2001). Because chlamydial LPS is often detected in the host cell cytosol,
especially more frequently than other chlamydial antigens, the presence of LPS
recognition molecules in epithelial cells would provide optimal detection potential
against chlamydial infection. It is becoming increasingly evident that the epithelial host
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cell is instrumental for initiating innate immune responses to intracellular bacteria and,
even though chlamydiae secrete proteins to counteract this response in the infected
cell, there may also be important consequences for chlamydial antigens that are
released from the host cell to be recognized by neighboring uninfected epithelial cells
via cross-presentation.
Chlamydiae are well equipped for survival within the host epithelial cell. Possessing
an array of effector proteins, chlamydiae can manipulate multiple host cellular
processes for the purpose of intracellular survival. Documented host-pathogen
interactions instigated by chlamydiae include (i) recruitment of actin and cellular signal
transduction regulators during entry, (ii) hijacking of trans-Golgi vesicles, multivesicular
bodies, and lipid bodies, (iii) exploitation of the microtubular network, (iv) recruitment of
host cell signaling molecules, (v) inhibition of host cell apoptosis, and (vi) degradation of
host transcription factors involved in MHC-I and MHC-II induction. Clearly, Chlamydia
employ a variety of effectors to manipulate its intracellular environment. The secretion
of antigens detailed in the present study may serve, ironically, to invoke an immune
response for chlamydial survival, perhaps by triggering persistence. Even an immune
response capable of eliminating chlamydiae in an active infection may fail in clearance
of chlamydiae present in a persistent infection. Chlamydial infection of the urogenital
tract may consist of regions of epithelia subject to differing infection states, i.e. active
infection of the cervix and persistent infection of the endometrium. On the other hand,
there may exist a state of alternating active and persistent infection. Either scenario, by
causing a sustained or cyclical inflammatory response, could explain the
immunopathology associated with chlamydial infection.
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The escape of chlamydial antigens may also have effects on the host cell that
indirectly influence pathogenesis. For instance, if the accumulation of chlamydial
antigens in the ER were to initiate ER stress, there could follow premature protein
destruction causing loss of cellular function or the accumulation of proteins in the ER as
toxic end products. Both of these defects would impair normal secretory function and
likely have an adverse effect on chlamydial development. Conversely, ER dysfunction
may, through an unknown mechanism, contribute to chlamydial propagation and
disease progression. Further understanding of Chlamydia-host cell interaction will help
define targets for chemotherapeutic and immunological intervention.
In summary, the findings herein introduce a novel mechanism for premature antigen
escape from the chlamydial inclusion via vesicles that may possess fusion capability
with the host cell ER. That chlamydial antigens were localized to the ER of infected
epithelial cells increases relevance of the ER during infection, particularly hinting
towards potential epithelial cell intracellular recognition and processing of antigens for
classical and non-classical T cell antigen presentation. Identification of cHsp60-2 as
iron-responsive emphasizes Chlamydia’s ability to combat stress by using multiple
avenues leading to persistence and highlights cHsp60-2 as a potential mediator of the
immune-mediated damage observed in chlamydial infection. As new tools emerge for
studying chlamydial biology and advances are made to further understand epithelial cell
immune capacity, there will follow discoveries that refine our knowledge of Chlamydiahost interactions and potentially lead to the development of a vaccine.
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